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Key messages  
This publication is a systematic Campbell review of the effect of the family therapy 
approach Family Behavior Therapy (FBT) for treatment for non-opioid drug use 
(e.g., cannabis, amphetamine, ecstasy or cocaine) among young people aged 11-21 
years.  
 
Youth drug use is a severe problem worldwide. Recent reports describe concerning 
trends in the use of drugs by young people and a lack of available treatment. FBT is a 
manual-based family therapy approach that seeks to reduce drug use among youth 
by identifying stimuli and triggers for drug taking, and teaching self-control and 
other skills to correct the problem behaviors related to drug use. This approach is 
based on the therapeutic premise that the family carries a profound influence on 
child and youth development and that interventions need to be flexible and tailored 
to the unique characteristics of the families. It is also argued that there is a need for 
interventions to be problem-focused, targeting first those patterns of behavior that 
most directly influence the youth’s drug use. 
 
After a rigorous search for all relevant studies conducted to date, we identified two 
randomized controlled trials with, respectively, 56 and 26 participants. We used 
meta-analysis to synthesize the empirical evidence on the effects of FBT on 
reduction of drug use frequency, family functioning, and risk behavior. The findings 
are as follows:  
 
- On drug usage: There is no evidence that FBT has an effect on reduction of 
drug use frequency compared to Individual Cognitive Problem-Solving 
(ICPS) and supportive counseling (SC).  
- On family functioning: FBT may improve family functioning as reported by 
parents compared to Individual Cognitive Problem-Solving (ICPS) and 
supportive counseling (SC). There is no evidence that FBT has an effect on 
family functioning as reported by youth compared to Individual Cognitive 
Problem-Solving (ICPS) and supportive counseling (SC). 
- On risk behavior: There is no evidence that FBT has an effect on risk 
behavior compared to Individual Cognitive Problem-Solving (ICPS) and 
supportive counseling (SC).  
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The evidence found was limited, as only two studies with very few participants were 
included in the data-analysis. The quality of the evidence is also limited. We were 
therefore unable to draw any firm conclusion regarding the effectiveness of the 
treatment. 
 
Overall, Family Behavior Therapy for the purpose of treating young people’s drug 
use has not been evaluated with sufficient rigor to unequivocally determine its 
effectiveness. 
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Executive summary/Abstract  
BACKGROUND 
Youth drug use is a severe problem worldwide, and the use of cannabis, 
amphetamine ecstasy and cocaine, referred to as non-opioid drugs, are strongly 
associated with a range of health and social problems.  
 
This review focuses on Family Behavior Therapy (FBT) as a treatment for young 
people who misuse non-opioid drugs. FBT is a manual-based family therapy 
approach. The program is behavior and skill-oriented. It is concerned with 
identifying psychological and situational stimuli and triggers presumed to be 
directly related to the youth’s drug use, and skills training to improve self-control. 
FBT is designed to accommodate diverse populations of youth with a variety of 
behavioral, cultural and individual preferences. FBT incorporates behavioral theory 
(reduction of undesired behavior by manipulating external reinforcement), 
structural family theory (in which the structure of the family influence the youth’s 
behavior) and strategic family theory (where treatment methods are problem-
focused and pragmatic). 
 
OBJECTIVES 
The main objective of this review is to evaluate the current evidence on the effects of 
FBT on reduction of drug use frequency for young people in outpatient treatment for 
non-opioid drug use and, if possible, to examine moderators of drug use reduction 
effects, specifically analyzing whether FBT works better for particular types of 
participants. 
SEARCH STRATEGY 
A relatively narrow search strategy to identify qualifying studies was performed. A 
wide range of electronic bibliographic databases were searched along with  
government and policy databanks, grey literature databases, citations in other 
reviews and in the included primary studies, hand searches of relevant journals, and 
Internet searches using Google. We also corresponded with researchers in the FBT 
field. Neither language nor date restrictions were applied to the searches.  
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SELECTION CRITERIA 
Studies eligible for inclusion in the review are required to meet several eligibility 
criteria. Studies must: 
 
• have involved a manual-based FBT treatment for young people aged 11-21 
years enrolled in outpatient treatment for non-opioid drug use; 
• have used experimental, quasi-experimental or non-randomized controlled 
designs; 
• have reported at least one eligible outcome variable measuring abstinence, 
reduction of drug use, family functioning, education or vocational 
involvement, retention, risk behavior or any other adverse effects; 
• not have focused exclusively on treating mental disorders; and  
• have had FBT as the primary intervention.  
 
DATA COLLECTION AND ANALYSIS 
The literature search yielded a total of 10,779 records which were screened for 
eligibility based on title and abstract. 99 potentially relevant records were retrieved 
and screened in full text, of which 7 studies were potentially relevant. Of these, two 
studies were data-extracted by the authors and included in the review. Meta-analysis 
was performed to examine the effects of FBT on drug use reduction, family 
functioning and risk behavior.  
 
RESULTS 
For the primary outcome of reduction in drug use frequency, measured at end of 
treatment, the standardized mean difference was 0.49 (95% CI -0.51, 1.50). At 12 
month post-intake, Azrin et al. (2001) found no statistically significant difference 
between FBT and the comparison treatment, SMD=-0.03 (95% CI -0.58, 0.52). For 
family functioning, measured at end of treatment, the standardized mean difference 
was 0.58 (95% CI 0.02, 1.13) reported by parents and 0.29 (95% CI -0.72, 1.30) 
reported by youth. At 12 month post-intake, Azrin et al. (2001) found no statistically 
significant difference between FBT and the comparison treatment for parent 
satisfaction or youth satisfaction with family functioning, SMD= -0.30 (95% CI -
0.86, 0.26) and SMD= 0.47 (95% CI -0.09, 1.04). For risk behavior, measured at end 
of treatment, the standardized mean difference was 0.29 (95% CI -0.16, 0.74). At 12 
month post-intake, Azrin et al. (2001) finds a statistically significant difference that 
favors the comparison treatment, SMD= -0.56 (95% CI -1.13, 0.00). 
 
Meta-analysis was not possible for the education outcomes as the measures are 
incomparable. None of the studies reported statistically significant effect sizes for 
school outcomes. Due to lack of data for the number randomized in both studies it is 
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not possible to report effects for retention. No other adverse effects are reported in 
the studies.  
 
AUTHORS’ CONCLUSIONS  
The main conclusion of the review is that there is a lack of firm evidence on the 
effect of FBT. There is a need for more research, and particularly a need for more 
methodologically rigorous studies in the field of treatment for young drug users.  
 
The aim of this systematic review is to explore what is known about the effectiveness 
of FBT for the purpose of reducing youth drug use, in order to contribute to an 
evidence-based approach in the treatment of young non-opioid drug users. The 
evidence found does not provide a basis for drawing conclusions about actual 
outcomes and impacts. Consequently, no substantive conclusion about the 
effectiveness can be made, resulting in neither support nor rejection of the present 
FBT treatment approach. 
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1 Background 
1.1  DESCRIPTION OF THE CONDITION 
Youth drug use1 that persists beyond curious experimentation is a severe problem 
worldwide (United Nations Office of Drugs and Crime (UNODC), 2010). Use of non-
opioid drugs such as cannabis, amphetamine and cocaine is strongly associated with 
a range of health and social problems, including delinquency, poor scholastic 
attainment, fatal automobile accidents, suicide and other individual and public 
calamities (Deas & Thomas, 2001; Essau, 2006; Rowe & Liddle, 2006; Office of 
National Drug Control Policy (ONDCP), 2000; Shelton, Taylor, Bonner & van den 
Bree, 2009). More than 20 million of the 12 to 25 year-olds in the US, and more than 
11 million of the 12 to 34 year-olds in Europe have used illicit2 drugs during the 
month prior to survey interviews in 2009 (Substance Abuse and Mental Health 
Services Administration (SAMSHA), 2010; European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA), 2010). Seven percent of Australian 12 to 17 year-
olds have used some kind of drug during the month prior to survey interviews in 
2008 (White & Smith, 2009). In Canada 26 percent of 15 to 24 year-olds had used 
illicit drugs during the past year (Health Canada, 2010).  
Not all young drug users progress to severe dependence. However, some do and may 
therefore require treatment (Liddle et al., 2004; Crowley, Macdonald, Whitmore & 
Mikulich, 1998). For example, 8.4 percent of 18 to 25 year-olds in the US are 
classified as needing treatment for illicit drug use, but less than one tenth of these 
young people actually receive treatment (National Survey on Drug Use and Health 
(NSDUH), 2007). Likewise among young people aged 12 to 17, 4.5 percent were 
estimated to be in need of treatment for a drug use problem, but only one tenth in 
this group actually received any (SAMSHA, 2010). Research calls attention to the 
significant gap between young people classified in need of treatment and young 
people actually receiving treatment (SAMSHA, 2010; NSDUH, 2007). 
 
There is a growing public concern regarding the effectiveness and high costs of 
available treatments for young people, and regarding the high rates of treatment 
dropout and post treatment relapse to drug use (Austin, Macgowan & Wagner, 
                                                        
1 The terms use, abuse and dependence will be used interchangeably throughout the review and refer to an addiction 
stage of non-medical drug usage.   
2 Cannabis, amphetamine, cocaine and other non-opioid and opioid drugs are illegal in most, but not all countries. 
For instance, use of cannabis in small amounts is tolerated in the Netherlands.  
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2005; Najavits & Weiss, 1994; Stanton & Shadish, 1997). Accordingly, treatment to 
help young drug users should be as engaging as possible in order to minimize 
dropouts and relapse (Simmons et al., 2008; National Institute on Drug Abuse 
(NIDA), 2009). The services provided should be empirically supported in order to 
increase the likelihood that (a) treatment will be successful, and (b) public spending 
is used to support the interventions with the most effect.  
 
Researchers point to the fact that many research projects have empirically validated 
different kinds of treatment approaches for young drug users as effective (e.g. Rowe 
& Liddle, 2006; Waldron, Turner & Ozechowski, 2006; Williams, Chang & Addiction 
Centre Adolescent Research Group, 2000; Austin et al., 2005). The current dilemma 
in the field of youth substance abuse treatment is that it is not clear what works best, 
as the research suggest that most interventions lead to reduced drug use. While 
there are some promising individual-based cognitive, cognitive-behavioral and 
motivational therapies (Waldron & Turner, 2008; Kaminer, 2008; Deas & Thomas, 
2001; Galanter & Kleber, 2008), family-based approaches may also show some 
promise. Family therapy covers a range of different interventions and is based on 
different manuals and varying theoretical sources such as behavioral and cognitive 
behavioral theory, structural and strategic family theory, and family systems theory 
(Williams et al., 2000; Austin et al., 2005). Some reviews have suggested that these 
family-based therapies are superior to individual-based programs in reducing youth 
drug use (Williams et al., 2000: Lipsey, Tanner-Smith & Wilson, 2010; Waldron, 
1997). 
 
Young people with persistent drug use have unique needs due to their particular 
cognitive and psychosocial development. Young people are specifically sensitive to 
social influence, with family and peer groups being highly influential. Youth drug 
treatments facilitating positive parental and peer involvement, and integrating other 
systems in which the young person participates (such as schools, social services, 
justice authorities) are key to youth drug reduction (NIDA, 2009). A number of 
studies and reviews have showed positive results for family therapies in general, but 
there is a need to synthesize individual study results for specific family therapies to 
determine whether and to what extent specific family therapy interventions work for 
young drug users (Williams et al., 2000; Austin et al., 2005; Waldron & Turner, 
2008; Kaminer, 2008; Deas & Thomas, 2001).   
 
This review explores the specific family-based intervention Family Behavior Therapy 
(FBT) (Azrin, Donohue, Besalel, Kogan & Acierno, 1994a; Donohue & Azrin, 2001; 
Donohue et al., 2009). The review attempts to clarify the effects of the FBT program 
for relevant groups of young people aged 11-21 years. It focuses on young people 
enrolled in treatment for drug use regardless of how their problem is labeled. 
Enrolment in treatment means that the severity of the young person’s drug use has 
caused a significant adult close to the young person (such as a teacher, parent, social 
services, or school counselor) to require treatment. FBT is delivered as outpatient 
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treatment3 to young people age 11-21 years living with their family. The review 
focuses primarily on non-opioid drug use4.  
This review is one in a series of reviews on manual-based family therapy 
interventions for young people in treatment for non-opioid drug use5. 
 
1.2  DESCRIPTION OF THE INTERVENTION 
FBT is a manual based family-oriented intervention for young people with drug use 
problems. FBT is a behavior focused family therapy in which young people’s drug 
use is understood in relation to family behavior problems.  
FBT is one of many family therapies that meet the general characteristics of manual-
based family therapies as it targets young people and their families as a system 
throughout treatment, and thereby recognizes the important role of the family 
system in the development and treatment of young people’s drug use problems 
(Liddle et al., 2001, Muck et al., 2001).  
FBT was developed in the late 1980s on request from the US National Institute on 
Drug Abuse (NIDA) (Donohue et al., 2009). The development of FBT was initially 
heavily inspired by the alcohol abuse program Community Reinforcement Approach 
(CRA), which was aimed at restructuring the environment to reinforce non-alcohol 
associated activities. FBT developed to have more emphasis on contingency 
contracting, impulse control strategies specific to drug use, and increased emphasis 
on involvement of family members in treatment. FBT is designed to accommodate 
diverse populations of youths with a variety of behavioral, cultural and individual 
preferences. FBT has evolved for use in severe behavioral disturbances known to co-
exist with substance use and dependence, and the core interventions have been 
enhanced to address several mental health related problems commonly occurring as 
comorbid conditions in drug use treatment participants (Austin et al., 2005; 
Donohue et al., 2009).  
                                                        
3 A Cochrane review has evaluated psychosocial interventions for substance abuse and misuse in young offenders in 
locked facilities (Townsend et al., 2009).  
4 Two Cochrane reviews have evaluated psychosocial treatments for treatment of opioid dependence (Amato et al., 
2011; Minozzi et al. 2010). 
5 Please see the following Protocols in the Campbell Library for further information:  
Maia Lindstrøm, Pernille Skovbo Rasmussen, Krystyna Kowalski, Trine Filges, Anne-Marie Jørgensen: Brief Strategic 
Family Therapy (BSFT) for young people in treatment for illicit non-opioid drug use. Campbell Systematic review 
2011:05 
Krystyna Kowalski, Pernille Skovbo Rasmussen, Trine Filges, Madina Saidj, Maia Lindstrøm, Anne-Marie Jørgensen:  
Multidimensional Family Therapy (MDFT) for young people in treatment for illicit non-opioid drug use. Campbell 
Systematic Review 2011:04 
And the Title Registration:  
Krystyna Kowalski, Maia Lindstrøm, Pernille Skovbo Rasmussen, Trine Filges, Anne-Marie Jørgensen: Functional 
Family Therapy (FFT) for young people in treatment for illicit non-opioid drug use. 
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1.2.1 Theoretical background 
FBT is a family systems approach that relies on structural and strategic family 
theory as well as behavioral family theory (Robbins & Szapocznik, 2000; 
Szapocznik, Hervis & Schwartz, 2003; Azrin et al., 1994a; Donohue & Azrin, 2001). 
Along with other family-systems based therapies, FBT builds on the assumption that 
families can be viewed as systems and as such each individual in the family is 
important for the family system as a whole (Poulsen, 2006). In family systems 
theory the family is perceived as a unique system consisting of interdependent and 
interrelated members. The family members are influenced by each other’s actions 
and are strongly related to each other, and as such they can be viewed as parts of a 
unique and changeable system. The behavior of each family member must be 
understood in relation to the family context. Young family member’s problematic 
behavior is associated with maladaptive social interaction patterns in the family, and 
therefore interventions must be implemented at the family level. The family itself is 
part of a larger social system, and as young people are influenced by their families, 
the family is influenced by the larger social (and cultural) systems in which they 
exist (Poulsen, 2006; Doherty & McDaniel, 2010; O’Farrell & Fals-Steward, 2008; 
Kaminer & Slesnick, 2005; Austin et al., 2005). Family therapies are concerned with 
the wider social context in which the individual and the family is embedded.   
The structural family theory is based on the idea that subsystems, structures and 
hierarchies within families influence or determine individual family members’ 
actions (Goldenberg & Goldenberg, 2008; Minuchin, 1985). In structural family 
theory social interactions are understood structurally, as repetitive patterns of 
interaction. The family structure can range from a supportive structure to a 
maladaptive structure. Either way the structure of interactions affects the family 
members and could play a pivotal part in maintaining positive as well as problem 
behavior (Poulsen, 2006; Doherty & McDaniel, 2010; O’Farrell & Fals-Steward, 
2008; Kaminer & Slesnick, 2005; Austin et al., 2005). The strategic theory-based 
dimension of FBT focuses on creating changes in behavior and interactions relevant 
to the identified problems within families, and in individual family members 
resisting changes (Goldenberg & Goldenberg, 2008).  
Behavioral theory focuses on observable behavior (i.e. symptoms, problems). It is 
characterized by an ongoing assessment of the behavior to be altered and a focus on 
enhancing or reducing targeted undesired/unwanted behavior(s) by manipulating 
external contingencies of reinforcement. Therapists teach and coach communication 
and problem solving skills, and the members of the young drug user’s family are 
trained to monitor and modify their own reinforcement contingencies. FBT is based 
on a behavioral conceptualization of drug use and drug use problems, where drugs 
are considered a strong primary reinforcer which is further reinforced by both 
physiological and situational stimuli (Austin et al., 2005; Donohue & Azrin, 2001). 
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FBT emphasizes contingency management, utilization of impulse control strategies 
specific to drug use scenarios, and explicitly monitors environmental stimuli 
relevant to drug use (Donohue et al., 2009).  
1.2.2 FBT components 
FBT incorporates multilevel components to target young people’s drug use, as well 
as the young person’s behavior, problem solving skills, family relationships and 
communication skills (Donohue & Azrin, 2001). The young person attends therapy 
sessions with at least one family member, typically one of the parents. In addition, 
the FBT program encourages involvement and participation of siblings and peers in 
therapy.  
FBT includes the following core foundation components:  
1. Program orientation  
The therapist will initially provide an overview of FBT to engage participants in 
treatment. During the sessions the reasons for referral and support methods that are 
most helpful to the young drug user and his or her family will be discussed. 
Furthermore the therapist will clearly “differentiate” him or herself from third 
parties, such as social service authorities and probation agencies (Donohue & Azrin, 
2001). It is important for the therapist to take an independent role in order to gain 
family members’ confidence and to navigate on behalf of the family to solve their 
problem (the young person’s drug use).  
 
2. Development of behavioral goals and contingency management  
The young person will be asked to identify relevant triggers and stimuli for drug use. 
These triggers and stimuli are targeted in treatment and guides the identification of 
behavioral goals. The aim of the behavioral contracting procedures is to establish an 
environment that facilitates reinforcement of behaviors associated with drug 
abstinence (Donohue & Azrin, 2001; Donohue et al., 2009; California Evidence-
Based Clearinghouse (CEBC), 2011; Achievement Center, 2011). The goals can be 
adjusted and new goals can be added during treatment, as needs may change and 
develop during the work with various FBT components during treatment. Focus can 
shift between different goals based on participants’ changing needs and behavioral 
development (Donohue et al., 2009).  
 
3. Standardized treatment plan  
When goals and contingencies are established, treatment is planned. In this process 
the young person and his/her parents are asked to determine which skill-based 
components are the most appropriate to include in treatment (Donohue et al., 2009; 
CEBC, 2011; Achievement Center, 2011).  
 
4. Assurance of basic necessities  
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Young people using drugs often experience problematic situations and difficulties 
such as dismissal from school or work, economical problems, and violence, which 
often disrupt treatment. The FBT component Assurance of basic necessities 
(Donohue et al., 2009) aims at teaching the young person (and parents) how to 
monitor conditions that have been found to increase the likelihood of problematic 
situations and difficulties, and integrate “urgency management” in their treatment 
plan (Donohue et al., 2009; CEBC, 2011; Achievement Center, 2011).     
 
5. Stimulus control  
The young person and his or her parents are asked to create two comprehensive 
lists; 1) A safe list of behavioral stimuli that decrease the young person’s likelihood 
of using drugs and 2) A risk list of behavioral stimuli that increase the likelihood of 
drug use. The young person and their parents are asked to monitor the time the 
young person spends on safe and risk behaviors. The therapist assists treatment 
participants in finding methods of spending more time with safe stimuli and less 
time with risk stimuli (Donohue & Azrin, 2001; Donohue et al., 2009; CEBC, 2011; 
Achievement Center, 2011). The therapist reviews the stimulus control items, and in 
this process the therapist has the opportunity to add goals to the “behavioral goals 
and contingency management” treatment component.  
 
Furthermore, within FBT young people and their parents are asked to select from a 
range of the following optional therapy components:  
 
Self control  
The young person is instructed to avoid locations, objects and events that stimulate 
drug cravings. Recognition of the stimuli is regarded as key in self-control, in order 
to stop or discipline drug related thoughts and reward goal-oriented, drug 
incompatible behavior (Donohue et al., 2009; Donohue & Azrin, 2001; CEBC, 2011; 
Achievement Center, 2011).    
 
Communication skills training  
Communication skills training is aimed at improving family communication through 
different component options:  
 I’ve got a great family. This component is aimed at assisting families in 
appreciating each other and the family’s positive qualities.  
 Positive request. This component assists the family in developing clear and 
positive communication, and aims at increasing the positive exchange 
between family members.  
 Arousal management. Various illicit drugs have been associated with 
increased irritability and stress, which could influence family relations 
negatively. The arousal management component aims at decreasing anger 
and aggression in the young people by teaching identification of the 
antecedents of anger and aggression (Donohue et al., 2009; Donohue & 
Azrin, 2001; CEBC, 2011; Achievement Center, 2011).     
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Training for skills associated with attending school and/or getting a 
job 
The aim of this optional component is to assist young drug users in achieving 
consistent school attendance or obtaining a job. Training is focused on disclosing 
positive qualities and skills relevant for schooling or work, such as interviewing 
techniques, and meeting potential employers or school officers.  
 
Financial management  
FBT focuses on teaching the young person to identify stimuli, prioritize spending 
and methods to manage and gain income in order to appropriately allocate 
resources and avoid financial crisis that may stimulate drug use (National Registry 
of Evidence-based Programs and Practices (NREPP), 2011; Donohue et al., 2009; 
Donohue & Azrin, 2001; CEBC, 2011).  
  
All FBT core and optional components aim at skills development and behavior 
change, and use role play and behavior rehearsals actively in treatment. FBT is 
designed to accommodate a diverse population of young people with varying cultural 
backgrounds, behavioral patterns and individual preferences. The range of eligible 
and optional components provides the opportunity for FBT to be flexible and 
tailored to the individual needs of the young person and family (CEBC, 2011; 
Donohue & Azrin, 2001; NREPP, 2011; Austin et al., 2005).    
 
Methods of enhancing motivation for treatment 
Retention being a challenge in drug treatments, FBT incorporates weekly phone 
calls to participants to enhance session attendance (Donohue et al., 2009). 
Furthermore, participants are screened prior to enrollment in FBT to determine 
issues that are contraindicative with participation in FBT treatment, such as the lack 
of a stable local residence or the lack of a significant other to attend sessions with. 
Therapists are trained to manage drug user’s lack of motivation for treatment and 
any non-compliance with therapeutic guidelines (such as refusing to do role-playing, 
forgetting to do assigned home-work, or arguing during therapy). Therapists 
evaluate participant’s behavior efforts and disclose this information to relevant 
authorities (e.g. the juvenile justice system, or social services). Participants are 
asked to rank the helpfulness of each intervention component immediately after 
termination, and the therapist can adjust the program based on these rankings in 
attempt to resolve discontent early in the therapeutic process. Therapists also rate 
participant’s level of active participation and these rating are sent to the referral 
agency. In cases of recurring non-compliance, the program supervisor will co-lead 
the next session with the therapist and provide on-site supervision and facilitate the 
management of difficult cases (Donohue et al., 2009). 
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1.2.3   Duration and setting  
FBT is a behavior and skill-oriented intervention that can include up to 20 treatment 
sessions of 1-2 hours. Duration ranges from 6-12 months. Delivery is flexible and the 
intervention can be delivered in an office-based setting or in the family home 
(Donohue et al., 2009).  
1.3  HOW THE INTERVENTION MIGHT WORK 
FBT has two primary objectives: 1) to reduce the young person’s drug use, and 2) to 
change behaviors associated with drug use in the young person and their family. The 
intervention aims at engaging young people and their families in therapy, improving 
family interactions, and skills training to assist in changing behaviors related to 
young people’s drug use. Randomized controlled trials and systematic reviews have 
shown that FBT can reduce drug use in participants, and contribute to reduction in 
behavioral problems (Austin et al., 2005; Deas & Thomas, 2001; Azrin et al., 1994a; 
Azrin et al., 1994b; Azrin et al., 1996; Azrin et al., 2001). The program outcomes may 
be affected by participant characteristics and program mechanisms. The participant 
characteristics that have been found to predict program drug use reduction or 
abstinence are history and severity of drug use, and higher levels of school 
attendance and functioning pretreatment (Williams et al., 2000). Practitioners 
require information about highly relevant participant characteristics such as age, 
gender, minority background, family composition (e.g., single parents) and co-
occurring conditions. These participant characteristics are potential predictors of 
treatment outcome and practitioners need to be able to assess and tailor the 
program to particular types of young drug users.  
1.3.1 Intervention mechanisms 
Treatment variables which have a positive impact on treatment outcomes have been 
identified across reviews of a range of treatments for youth drug use (Williams et al., 
2000; Austin et al., 2005).  
Treatment completion is the variable which has the most consistent relationship to 
drug use reduction (Williams et al., 2000; Austin et al., 2005). Early alliance 
building has been found to predict the likelihood that the young people complete 
treatment and reduce drug use (Waldron & Turner, 2008). Consequently, it remains 
unclear if this is a direct treatment impact, or an indicator for treatment motivation, 
which is identified as another key variable to positive treatment outcome. Either 
way, these findings point to the importance of the FBT components ‘program 
orientation’ and ‘methods for enhancing motivation for treatment’ as key 
mechanisms, influencing treatment compliance and attendance. In FBT, the 
motivational enhancement mechanisms has two aspects: program orientation are 
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the steps a therapist takes to prepare the family for change, and methods for 
enhancing motivation for treatment are techniques performed by the therapist to 
ensure participants active participation and retention in treatment.  
Engagement and retention strategies as well as strategic multi-component treatment 
planning based on behavioral assessment are other possible mechanisms to 
behavior change, related to the strategic focus of FBT. Engagement and retention are 
major challenges in treatment of young people with drug use problems. FBT 
includes pre-treatment engagement strategies as well as active involvement of young 
people and their parents in treatment planning. Furthermore, the intervention is 
based on behavioral assessments and tailored to the participants as well as family 
behavioral problems, which is assumed to be part of the explanation for FBT’s 
impact on young people’s drugs use.   
Motivation is seen as being key to positive treatment outcome (Williams et al., 
2000), and is also linked to the support and influence of the family system. The 
ability of the family system to influence the young person to a non-drug-using 
lifestyle is a possible mechanism of change related to the family systems focus of 
FBT. Studies have found that FBT positively influences parent satisfaction with 
youth, family relations, youth psychological functioning (particularly there is a 
decrease in youth depression among recipients of FBT), and contributes to the 
reduction in young people’s drug use (Azrin et al., 1994a; Austin et al., 2005; Azrin 
et al., 1994b; Azrin et al., 2001; Deas & Thomas, 2001). Azrin et al., 1994b and Azrin 
et al., 1996 attribute reductions in drug use to active parental participation in the 
young person’s drug treatment. Family and peer support for non-drug usage is 
related to improved relapse management (Williams et al., 2000).  
Communication skills training and positive reinforcement are possible mechanisms 
of behavior change, related to the behavioral focus of FBT. Studies have found that 
FBT participants experience improved family relations (Azrin et al., 1994a; Austin et 
al., 2005; Azrin et al., 2001; Deas & Thomas, 2001). Improvements in family 
relations and family behavior may be related to the FBT skills training in family 
communication, social support and contracting procedures (Azrin et al., 1994a). 
Some studies have suggested that problem behavior is reduced from pre- to post- 
treatment measurement, also for young people with conduct disorder diagnosis 
(Austin et al., 2005; Azrin et al., 1994a; Azrin et al., 2001; Deas & Thomas, 2001, 
William et al., 2000). These findings suggest that youth behavior is improved and 
that skills training and positive reinforcement may support the young people in 
abstaining and dealing with possible relapse to drug use. Azrin et al. (1996) suggest 
that the use of direct contingencies of reinforcement by the therapist or family on 
drug usage positively affect drug use in the short and long term.  
 
The behavioral focus, family systems focus, and the strategic focus are all possible 
explanations of intervention impact. These mechanisms influence family behavior 
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and functioning, and ultimately facilitate changes in young people’s drug use 
problems.  
1.4  WHY IT IS IMPORTANT TO DO THIS REVIEW 
Persistent drug use among young people is a significant social problem, and 
treatment of young people’s drug use is challenging and costly, not least because 
treatments for drug use problems in youth are plagued by high dropout rates and 
post-treatment relapse to drug use. Research suggests that nearly half of the young 
drug users never complete drug use treatment (Substance Abuse and Mental Health 
Services Administration (SAMSHA), 2008). There is a need to identify effective 
treatments for addressing young people’s drug use problems, and to reduce 
treatment dropout and post-treatment relapse. Young drug users who remain 
untreated are at risk of progression to severe dependence. Furthermore the growing 
interest among policy makers in increasing funding for empirically supported 
interventions is a strong motivation to add to the evidence base with a systematic 
review on a potentially promising treatment for young drug users. 
  
We identified five narrative reviews and four quantitative reviews that examined 
FBT for drug using youth. The majority of these conclude that more research is 
needed on the effects of FBT, on its moderators, on identifying of which subgroups 
of youth may be more likely to respond, and on how treatments can be tailored to 
individual need. Each of the five narrative reviews considered more than one 
intervention. Austin et al., 2005, Williams et al., 2000, Deas & Thomas, 2001, and 
Hogue & Liddle, 2009 all reported generally positive effects for FBT. However, all 
base their conclusions about FBT solely on the results of a single study; Hogue & 
Liddle review was based on Azrin et al., 2001, whereas the other three reviews based 
their conclusions on Azrin, Donohue, Besalel, Kogan & Acierno, 1994a. We also 
identified four quantitative reviews (Bender, Tripodi, Sarteschi & Vaughn, 2011; 
Vaughn & Howard, 2004; Bender, Springer & Kim, 2006; Waldron & Turner, 2008). 
Bender et al., 2011 and Vaughn & Howard, 2004 drew conclusions about FBT based 
on a single study (Azrin et al., 1994a). Vaughn & Howard, 2004 concluded that for 
FBT there was “evidence of clinically meaningful effect (ES > .20) with relatively 
strong designs and less than 1-year follow-up and no replication”. Bender et al., 
2011 used meta-analysis to evaluate family therapy and individual therapy for drug-
using youth, and found that FBT yielded large effects (> .80), again based solely on 
Azrin et al., 1994a. Waldron & Turner (2008) concluded, based on the Azrin et al. 
(2001) study, that “other family models,” which included FBT, “are probably 
efficacious, pending replication by independent research teams.” Bender et al., 
2006 reviewed the effectiveness of several interventions for dually diagnosed 
adolescents and concluded there was “a small treatment effect favoring the FBT 
group” for the reduction of substance use, although this too was based on a single 
study (Azrin et al., 2001). 
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There have thus been several studies which have indicated that FBT could be a 
promising treatment for young people with non-opioid drug use. By aggregating 
individual studies’ results on FBT this review will contribute to the knowledge about 
treatment of young drug-users and their families. The review will inform practice by 
exploring the effects of FBT for relevant user groups.  
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2 Objective of the review 
The aim of this review is to evaluate the current evidence on the effects of FBT on 
drug use reduction for young people in treatment for non-opioid drug use.  
A further objective, if possible, is to examine moderators of drug use reduction 
effects, specifically analyzing whether FBT works better for particular types of 
participants.    
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3 Methods 
3.1  TITLE REGISTRATION AND REVIEW PROTOCOL  
The title for this systematic review was registered in The Campbell Collaboration on 
20 June, 2011. The review protocol was approved on 18. April, 2012. Title 
registration and protocol are available at:  
 http://www.campbellcollaboration.org/library.php.  
 
3.2  CRITERIA FOR CONSIDERING STUDIES FOR THIS 
REVIEW 
3.2.1    Types of studies   
The study designs eligible for inclusion in the review were:  
 Controlled trials (all parts of the study are prospective, i.e. recruitment of 
participants, assessment of baseline, allocation to intervention, selection of 
outcomes and generation of hypotheses; Higgins & Green, 2008): 
o RCTs - randomized controlled trials 
o QRCTs - quasi-randomized controlled trials (where participants are 
allocated by means such as alternate allocation, person’s birth date, 
the date of the week or month, case number or alphabetical order) 
o NRCTs - non-randomized controlled trials (where participants are 
allocated by other actions controlled by the researcher such as 
location difference or time difference)   
 
We did not find any relevant quasi-randomized or non-randomized studies for 
inclusion in this review.  
 
3.2.2 Types of participants 
The population included in this review comprised young people age 11-21 years who 
were enrolled in a manual-based FBT out-patient treatment for non-opioid drug use 
(e.g., cannabis, amphetamine, ecstasy or cocaine). 
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Definitions of young people, and the age in which a person is considered a young 
person and may be entitled special services, such as drug treatment varies 
internationally (United Nations, 2011). Age group distinctions for young people are 
unclear, as the boundaries are fluid and culturally specific (Weller, 2006). 
Furthermore, young people start experimenting with illegal drugs at different ages 
in different countries (Hibell et al., 2009). Similarly, patterns of independence from 
parents and of independent living vary internationally for young people. In order to 
encapsulate these international differences we set the age range from 11 to 21 years 
(Hibell et al., 2009; United Nations, 2011; SAMHSA, 2010; Danish Youth Council, 
2011).  
Because family interactions are cardinal in FBT, we included only out-patient 
interventions in order to evaluate effects of FBT on youth living with their family..  
No universal international consensus exists concerning what categories to use when 
classifying drug users6, and different assessment tools and ways of classifying the 
severity of drug use are applied in different research studies (American Psychiatric 
Association, 2000; World Health Organisation (WHO), 2011; Nordegren, 2002). We 
chose to include participants regardless of formal drug use diagnosis: the main 
criterion for inclusion was that the young person had been enrolled in treatment for 
drug use (i.e. intervention or comparison condition). Referral to and enrolment in 
treatment required a level of drug use to the extent that the young person, his/her 
parent or significant other, or a representative of a statutory authority, had found it 
necessary to solicit or require treatment. We therefore defined the population as 
young people referred to treatment, or in treatment, for using non-opioid drugs.  
3.2.3 Types of interventions 
The review includes outpatient manual-based FBT interventions of any duration 
delivered to young people and their families (see 1.2 Description of the 
intervention). We included FBT outpatient interventions that did not include 
overnight stays in a hospital or other treatment facility.  
We also excluded cases where the young drug user was placed outside the family 
home (e.g., in-patient treatment and incarceration in a locked facility) where the 
core condition of the program will be seriously compromised. 
                                                        
6 Different systems classify clients into different categories, e.g., users, misusers and dependents. These specific 
categorizations are used in the Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric 
Association, 1994, 2000). While the DSM-IV is a widely used classification systems, other relevant classification 
systems such as the International Statistical Classification of Diseases and Related Health problems (ICD, now ICD-
10) developed by the World Health Organisation (WHO) are also in wide use. Differences between the classification 
systems concern both terminology and categorization criteria. For example the DSM-IV includes the category 
‘abuse’, while the ICD-10 explicitly avoids this term on the grounds of its ambiguity; harmful use and hazardous use 
are the equivalent terms in WHO usage, but the categories are not identical while the ICD-10 solely operates with 
physical and mental criteria,  the DSM-IV also includes social criteria (WHO, 2011, Nordegren, 2002). 
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Eligible comparison conditions were no intervention, waitlist controls and 
alternative interventions, as we are interested in both absolute and relative effects. 
Due to ethical considerations and nature of the problem we anticipated the 
likelihood of a no treatment control group to be small. We expected and found that 
the most frequent comparison was alternative interventions (Lipsey et al., 2010).  
3.2.4 Types of outcomes 
We included the following outcomes: 
 
Primary outcomes  
 Abstinence or reduction of drug use as measured by: 
 Biochemical test (e.g., urine screen measures for drug use);  
 Self-reported estimates of drug use (e.g., Time-line Follow Back 
interview; Sobell & Sobell, 1992); 
 Psychometric scales (e.g., Addiction Severity Index; McLellan, 
Luborsky, Woody & O’Brien, 1980). 
Secondary outcomes  
 Family functioning (e.g., measured by the Beavers Interactional 
Competence Scale; Beavers & Hampson, 2000). 
 Education or vocational involvement (e.g., measured by grade point 
average, attendance, self-reported or reported by authorities, files, 
registers, or employment record). 
 Retention (e.g., measured by days in treatment, completion rates and/0r 
attrition rates). 
 Risk behavior, such as crime rates, prostitution (e.g., measured by self-
reports or reports by authorities, administrative files, registers). 
 Other adverse effects (e.g., measured by rates of hospitalization, suicide 
and over-doses).  
The primary outcome is abstinence or reduction of drug use as the overall review 
question is to evaluate current evidence on FBT’s effects on young people in 
treatment for drug use. We sought evidence on how to best reduce or eliminate drug 
use, as drug use is understood as the young people’s primary problem.  
 
3.3  SEARCH METHODS FOR IDENTIFICATION OF STUDIES 
The searches were run by one review author (AKJ and a member of the review team 
PVH). 
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3.3.1 Electronic searches  
Relevant studies were identified through electronic searches of bibliographic 
databases, government and policy databanks. No language or date restrictions were 
applied. 
The following bibliographic databases were searched: 
 
Bibliotek.dk searched until October, 2014 
BIBSYS searched until October 12, 2014 
CINAHL searched until June 12, 2011  
Cochrane Library searched until October, 2014 
Criminal Justice Abstracts searched until October, 2014 
Embase searched until October, 2014 
ERIC searched until October, 2014 
LIBRIS searched until October, 2014 
Medline searched until October, 2014 
PsycINFO searched until October, 2014 
Science Citation Abstract searched until October, 2014 
Social Care Online searched until October, 2014 
Social Science Citation Abstract searched until October, 2014 
SocINDEX searched until October, 2014 
 
3.3.2 Search terms 
An example of the search strategy for MEDLINE searched through the Ovid 
platform is listed below. This strategy was modified for the other databases (see 
appendix 12.1). 
1. FBT or BFT.af. 
2. Famil* adj1 Behavio$r* adj1 therap*.af. 
3. 1-2/or 
 
Due to the narrow search strategy, we performed extensive searches of the grey 
literature and conducted hand searches, as described below.  
 
3.3.3 Searching other resources: Snowball search 
The review authors checked the reference lists of other relevant reviews and the two 
included primary studies for new leads. We identified 16 leading international 
experts who have published on the subject, and contacted them individually in 
attempt to identify unpublished and ongoing studies. We provided the experts with 
 27      The Campbell Collaboration | www.campbellcollaboration.org 
the inclusion criteria for the review along with the list of included studies, asking for 
any other published, unpublished or ongoing studies relevant for the review.  
3.3.4 Searching other resources: Hand search 
The following international journals were hand searched: 
 Addiction 
 Journal of Consulting and Clinical Psychology 
 Journal of Substance Abuse Treatment 
 Journal of Clinical and Adolescent Psychology 
 Research on Social Work Practice 
Searching were performed on editions from 2011 to the point of review in attempt  to 
capture any relevant studies recently published and therefore not identified in the 
electronic search.  
 
3.3.5 Grey literature  
Additional searches were made using Google and Google Scholar and we checked 
the first 150 hits. OpenGrey (http://www.opengrey.eu/) was used to search for 
European grey literature. Copies of relevant documents were made and we recorded 
the exact URL and date of access for each relevant document.  
In addition we searched these sites: 
National Institute on Drug Abuse (NIDA) http://www.nida.nih.gov/nidahome.htm 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
http://www.emcdda.europa.eu/index.cfm 
Substance Abuse and Mental Health Services Administration (SAMHSA) 
http://www.samhsa.gov/ 
 
3.4  DATA COLLECTION AND ANALYSIS 
3.4.1     Selection of studies  
One review author (MS) and one member of the review team (SLO7) independently 
screened all titles and available abstracts to exclude studies that were clearly 
irrelevant. Studies considered eligible by at least one of the reviewers was retrieved 
in full text. The full texts were then screened by one reviewer (MS) and one member 
of the review team (SLO) to determine study eligibility based on the inclusion 
criteria. Any disagreements on eligibility were resolved by discussion.  
 
Reasons for exclusion were documented for five studies that initially appeared 
relevant for the review. However none of these fulfilled our inclusion criteria and all 
were excluded (see sections 4.2.2, 8.2 and 9.2). The study inclusion screening sheet 
                                                        
7 Stine Lian Olsen was a member of the review team and assisted the review authors with screening. 
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was piloted and adjusted as required by the review authors and used throughout 
screening. The overall search and screening process is illustrated in a flow-diagram 
(figure 11.1). 
 
3.4.2 Data extraction and management 
Two review authors (ML & MS) independently coded and extracted data from the 
two included studies. The data extraction sheet was piloted and revised as necessary. 
Any disagreements were resolved by discussion. Data and information was extracted 
on; characteristics of participants (e.g., age, gender, and drug use history), 
intervention characteristics and control conditions, research design, sample size, 
outcomes and results. Extracted data were stored electronically in Excel. 
 
3.4.3 Assessment of risk of bias in included studies 
We assessed the methodological quality of studies using a risk of bias model 
developed by Prof. Barnaby Reeves in association with the Cochrane Non-
Randomised Studies Methods Group (Reeves, Deeks, Higgins, & Wells, 2011) 8. This 
model, an unpublished extension of the existing Cochrane Collaboration’s risk of 
bias tool (Higgins & Green, 2008), covers both risk of bias in RCTs and in NRCTs 
that have a well-defined control group.   
The extended model is organized and follows the same steps as the existing Risk of 
Bias model according to the Cochrane Hand book, chapter 8 (Higgins & Green, 
2008). The extension to the model is explained in the three following points: 
1) The existing Cochrane risk of bias tool needs elaboration when assessing non-
randomized studies because, for non-randomized studies, particular attention must 
be paid to selection bias/risk of confounding. The extended model therefore 
specifically incorporates a formalized and structured approach for the assessment of 
selection bias in non-randomized studies9 by adding an explicit item about 
confounding (Reeves et al. 2011). It is based on a list of confounders considered 
important and defined in the protocol for the review. The assessment of 
confounding is made using a worksheet where for each confounder it is marked 
whether the confounder was considered by the researchers, the precision with which 
it was measured, the imbalance between groups and the care with which adjustment 
was carried out. This assessment will inform the final risk of bias score for 
confounding. 
2) Another feature of non-randomized studies that make them at greater risk of bias 
compared to RCTs is that RCTs must have a protocol in advance of starting to recruit 
                                                        
8 This risk of bias model was introduced by Prof. Reeves at a workshop on risk of bias in non-randomized studies at 
SFI Campbell, February 2011. The model is developed by the Cochrane Non-Randomized Studies Method Group 
(NRSMG). 
9 The extended model was developed to ensure standardization of guidelines and procedures in the Risk of Bias 
assessment of NRS.  
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whereas non-randomized studies need not. The item concerning selective reporting 
therefore also requires assessment of the extent to which analyses (and potentially 
other choices) could have been manipulated to bias the findings reported, e.g., 
choice of method of model fitting, potential confounders considered/included. In 
addition the model includes two separate yes/no items asking reviewers whether 
they think the researchers had a pre-specified protocol and analysis plan. 
3) Finally the risk of bias assessment is refined, making it possible to discriminate 
between studies with varying degrees of risk. This refinement is achieved with the 
addition of a 5-point scale for certain items (see the following section Risk of bias 
judgment for details).  
The refined assessment is pertinent when thinking of data synthesis as it 
operationalizes the identification of studies (especially in relation to non-
randomized studies) with a very high risk of bias. The refinement increases 
transparency in assessment judgments and provides justification for not including a 
study with a very high risk of bias in the meta-analysis. 
 
Risk of bias judgment items and assessment 
The risk of bias model used in this review is based on 9 items (see section 10.2 for 
Risk of Bias tool). 
The 9 items refer to   
 sequence generation (Judged on a low/high risk/unclear scale – NRCT will 
automatically have high risk of bias ) 
 allocation concealment (Judged on a low/high risk/unclear scale)  
 confounders (Judged on a 5 point scale/unclear, only relevant for non-
randomized studies, i.e. NRCT)  
 blinding (Judged on a 5 point scale/unclear)  
 incomplete outcome data (Judged on a 5 point scale/unclear)  
 selective outcome reporting (Judged on a 5 point scale/unclear)  
 other potential threats to validity (Judged on a 5 point scale/unclear ) 
 a priori protocol (Judged on a yes/no/unclear scale) 
 a priory analysis plan (Judged on a yes/no/unclear scale) 
The assessment was based on pre-specified questions (see section 10.2). “Yes” 
indicates a low risk, “No” indicates a high risk of bias, and “Unclear” indicates an 
unclear or unknown risk of bias. In the 5 point scale 1 corresponds to No/Low risk of 
bias (e.g., 1 = a high quality RCT) and 5 corresponds to Yes/High risk of bias (e.g., 
5= too risky, too much bias, e.g., a poor quality study). A judgment of 5 points on 
any of the items assessed translates to a risk of bias so high that the findings would 
not be considered in the data synthesis (because they are more likely to mislead than 
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inform) (see section 10.2). None of the included studies in the review or parts 
thereof were judged 5 on the risk of bias scale.  
Confounding was not relevant in this review since we did not find any NRCTs 
meeting the inclusion criteria.  
 
Assessment 
Two review authors (ML & MS) independently assessed the risk of bias for each 
included study as described in the previous sections. Disagreements were resolved 
by discussion and consulting a third reviewer with content and statistical expertise 
(TF). We reported the risk of bias assessment in tables (section 9.3) for both 
included studies.  
 
3.4.4 Measures of treatment effect  
Standardized mean differences (SMD) were used as the effect size metric for drug 
use, family functioning and risk behavior; the data used for these calculations were 
means, standard deviations and sample size. RevMan 5.0 and Excel software were 
used for storing data and statistical analyses. 
 
3.4.5 Unit of analysis issues 
We planned to take into account the unit of analysis of the studies to determine 
whether individuals were randomized in groups (i.e. cluster randomized trials), 
whether individuals may have undergone multiple interventions, whether there were 
multiple treatment groups and whether there were multiple publications for some 
studies. 
 
Cluster randomized trials 
No cluster randomized trials were included in the review.  
 
Multiple interventions per individual  
We did not find any studies with multiple interventions per individual.  
 
 
Multiple intervention groups 
We did not find any studies with multiple intervention groups.  
 
 Multiple publications 
We did not find multiple publications for any studies.  
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Multiple time points and outcomes 
All follow-up durations reported in the primary studies were recorded. It was 
possible to group time points at end of treatment (6 month post-intake). Only one 
study reported outcomes at the 12 month post-intake and we performed separate 
analyses for these time points. Multiple measures of drug use were reported. We 
analyzed the measure that studies had in common; days of drug use per month. 
Multiple measures of risk behavior were reported. We analyzed the measure that 
studies had in common; number of arrests. 
 
3.4.6 Dealing with missing data and incomplete data 
We assessed missing data and recorded attrition rates for the two included studies. 
We were not able to discern reasons for attrition for either study. We contacted 
primary authors for both studies requesting data that was missing on the exact 
number of participants randomized, but received no reply. 
  
Intention to treats analysis 
Neither of the included studies used ITT methods.   
 
3.4.7 Assessment of heterogeneity  
Heterogeneity among primary outcome studies was assessed with Chi-squared (Q) 
test, and the I-squared, and τ-squared statistics (Higgins, Thompson, Deeks, & 
Altman, 2003). Any interpretation of the Chi-squared test was made cautiously on 
account of its low statistical power. 
 
3.4.8 Assessment of publication bias 
Reporting bias refers to both publication bias and selective reporting of outcome 
data and results. Selective reporting has been dealt with in the risk of bias 
assessment and any concerns are reported in section 4.3.6. 
As we were able to include only two studies in this review, our plans for funnel plots 
and related methods were not feasible. 
 
3.5  DATA SYNTHESIS 
Neither of the two included studies were coded as 5 on the Risk of Bias 5 point scale 
(described in section 3.4.3), and both studies are included in the data synthesis 
where possible. We did not find any studies comparing FBT to a no treatment 
condition, or to untreated wait list controls, and we are therefore unable to reach 
any conclusion about the absolute effects of FBT. The analysis of the relative effects 
of FBT (versus other interventions) was conducted on studies that compared FBT to 
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Individual Cognitive Problem-Solving and Supportive Counseling. All follow-up 
durations reported in the primary studies were recorded. The two studies both 
reported averaged scores over the six months during treatment, which could be 
pooled. Only one study reported outcomes at 12 months post-intake and we 
performed separate analyses for these time points. 
 
All analyses were inverse variance weighted using random effects statistical models 
that incorporate both the sampling variance and between study variance 
components into the study level weights. Random effects weighted mean effect sizes 
were calculated using 95% confidence intervals. We provide a graphical display 
(forest plot) of effect sizes in section 4.4. 
 
3.5.1  Moderator analysis/subgroup analysis and investigation of 
heterogeneity  
We did not identify sufficient studies to allow subgroup analysis to be conducted.  
 
3.5.2  Sensitivity analysis 
We did not identify sufficient studies to allow any sensitivity analyses to be 
conducted.  
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4 Results  
4.1  RESULTS OF THE SEARCH 
We ran the searches during May and June 2011 and updated them in October 2014. 
The joint results of the searches are summarized in the flow chart in Section 11. 
 
We searched fourteen bibliographic databases, and performed an extensive search 
for grey literature, and hand searched five core journals from 2011 to submission 
(see section 3.3). 
 
A total of 10,799 potentially relevant records were obtained from the electronic 
search after excluding duplicates (database search: 5,612 records, grey literature 
search: 977 records, hand search, snowball etc.: 4,190 records). 
 
The results were screened based on title and abstract and 99 records were retrieved 
and screened in full text. Of these, 97 did not fulfill the screening questions and were 
excluded. Five of the 97 excluded studies appeared relevant at first sight, but were 
excluded after careful screening.  
 
One paper from the database literature search was included, and one paper from 
snowball search was included. No papers from hand searching and grey literature 
were included.  
 
A total of 2 studies, reported in 2 separate papers, met the inclusion criteria and 
were vetted by the reviews authors.  
 
See section 4.2 for further details of the included and excluded studies. 
 
4.2  DESCRIPTION OF THE STUDIES 
4.2.1 Included studies 
Two studies met our inclusion criteria:  
 
Azrin, Donohue, Teichner, Crum, Howell & DeCato (2001) is an RCT on the effects 
of FBT on drug using youth aged 12-17 with a dual diagnosis of substance use and 
conduct disorder, performed in the US. The study was funded by the National 
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Institute of Mental Health, and published in Journal of Child & Adolescent 
Substance Abuse, volume 11 (1), 2001. In the following we will refer to this study as 
Azrin 2001.  
 
Azrin, Donohue, Besalel, Kogan & Acierno (1994a) is an RCT on the effects of FBT 
on drug using youth age 13-18, performed in the US. The study was funded by the 
National Institute of Drug Abuse, and published in Journal of Child & Adolescent 
Substance Abuse, volume 3 (3), 1994. We will refer to this study as Azrin 1994.    
 
Nathan Azrin is the developer of the FBT program and Bradley Donohue is the 
current program director for FBT.  
 
Design 
 
Both included studies are described by the investigators as RCTs. Participants in 
Azrin 2001 were randomized by matched pairs when possible. Matching was based 
on age, days of monthly drug use, types of drugs used, and the problem and intensity 
scales of the Eiberg Child Behavior Inventory (ECBI). Participants in Azrin 1994 
were randomized in matched pairs at the family level. Fourteen of the participants in 
Azrin 1994 had participated in an earlier trial by Azrin, McMahon, Donohue, 
Besalel, Lapinski, Kogan, Acierno & Galloway (1994b) and it is unclear how these 14 
participants were distributed in the current study design. 
 
Sample size 
 
Sample size for both studies is unclear as total number of participants randomized 
to treatment and control is not reported. In Azrin 2001, 178 participants met 
inclusion criteria, and 88 participants attended 3 assessment sessions and 
completed at least 1 treatment session. 56 participants completed 8 or more 
treatment sessions and are included in the analysis. However, it remains unclear 
how many participants were randomized. In Azrin 1994 the number of participants 
randomized is not reported. Azrin 1994 state as an inclusion criterion that 
participants needed to have completed 4 or more treatment sessions, and be willing 
to provide drug use data for 6 months following initiation of treatment. 26 
participants completed 4 or more treatment sessions and were included in the 
analysis.  
 
Participants 
 
The age of participants in the two included studies ranged from 12 to 18 years. The 
majority were male. In Azrin 2001, 25 percent of participants were living in single 
parent families. The proportion with a minority background in the two included 
studies ranged from 19 to 21 percent. Cannabis was the main drug used by the 
participants in both studies. 
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Table 4.2.1 Participant characteristics 
 Azrin 1994 Azrin 2001 
Age range (Mean), years 13-18 (16.0) 12-17 (15.4) 
Gender, male 77% 82% 
Family composition, single parent households - 25% 
Ethnicity, Minority 19% 21% 
Main drug used Cannabis Cannabis 
 
Comorbidity was present in the majority of participants in Azrin 2001, where 76 
percent had a dual diagnosis of substance use/dependency and conduct disorder. 
Azrin 1994 provided no information on comorbidity.. Azrin 2001 excluded youth 
with a diagnosis of mental retardation or psychotic disorder, whereas Azrin 1994 
excluded youth receiving psychological or psychiatric treatment. There may 
therefore be an imbalance in the population’s comorbidity between the two studies.  
The two studies differed in the way participants were recruited: in Azrin 2001 71% 
were externally mandated by the court or by another outside agency; in Azrin 1994 
participants were recruited from agencies, schools, and newspaper advertisements.  
 
Inclusion criteria in included studies 
 
Inclusion criteria in Azrin 2001 were:  
 participants aged 12-17 years; 
 present symptoms consistent with DSM-V diagnosis of conduct disorder plus 
substance abuse/dependency; 
 participants living with parents and within 30 minutes of the assigned clinic; 
 no diagnosis of mental retardation or psychotic disorder; 
 not receiving psychological intervention; 
 at least one parent is willing to provide transportation to treatment and 
participate in treatment.  
 
Inclusion criteria in Azrin 1994 were:  
 participants aged 13-18 years;  
 have engaged in illegal drug use other than or in addition to alcohol use during 
past month; 
 not receiving psychological/psychiatric treatment; 
 residing within 12 miles of the counseling facility;  
 have resided locally for 6 months prior to enrollment, and not have plans for 
moving outside local area.  
 
Exclusion criteria 
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Neither of the two included studies reported any exclusion criteria.  
 
Experimental interventions in included studies 
 
In Azrin 2001, youth and parents attended sessions together and separately, and 
performed assessments and ratings together and individually. Treatment duration 
was fifteen sessions delivered over the course of 6 months. During the first three 
months, participants had weekly sessions, decreasing to biweekly sessions, and 
eventually to monthly. Sessions were of 90 minutes duration initially, decreasing to 
60-75 minute sessions from the seventh to fifteenth session. The average number of 
FBT sessions attended was 13.48.  
 
In Azrin 1994, parents participated in all sessions. Duration of treatment was 6 
months with sessions twice weekly initially, and then reduced in frequency as 
progress became apparent. The average number of 2-hour sessions attended was 
fifteen.  
 
Control conditions in included studies 
 
The control condition in Azrin 2001 was manual based Individual Cognitive 
Problem- Solving (ICPS), with a cognitive focus on problem solving and without 
behavioral features. Duration of treatment was 15 sessions delivered over 6 months. 
During the first three months participants had weekly sessions, decreasing to 
biweekly sessions, and eventually to monthly. Sessions were 90 minutes initially, 
decreasing to 60-75 minute sessions from the seventh to fifteenth session. The 
average number of ICPS sessions attended was 13.70.  
 
The control condition in Azrin 1994 was Supportive Counseling, designed to include 
the principal features of supportive counseling, emphasizing expression of feeling, 
self-attempts at insight, discussion of drug related experiences and feelings, and 
group interaction. Youth attended individual one-hour sessions weekly and two-
hour group sessions weekly, parents attended sessions once monthly. Treatment 
duration was 6 months with a mean of 15 sessions attended.  
 
Time points for measurements 
 
Azrin 2001 provided assessments at six months prior to the initial intake session, 
during the six months of treatment, and at six months post-treatment for measures 
of drug use and arrests. Drug use (reported as days per month using drugs) was 
measured continuously during the 6 months preceding treatment, during the 
treatment period and during the six months following the end of treatment. The 
reported results were averaged scores over each six month period. Arrest scores 
were reported as frequency of arrests during the six months period preceding, 
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during and after treatment. Family functioning measures were based on interviews 
performed at intake, end of treatment and six months after end of treatment.   
 
Azrin 1994 provided assessments one month preceding treatment and during the six 
months of treatment. Drug use, family functioning and arrests were measured 
repeatedly and scores averaged over one month prior to treatment and during the 
six months of treatment.    
 
Primary outcome 
 
Youth drug use 
Abstinence or reduction of youth drug use was reported using urine drug screens in 
Azrin 2001 and Azrin 1994. Both studies measured days using drugs during a 28-30 
day period. A decreased number of days using drugs indicates reduction of drug use. 
Azrin 2001 combined the urine screens with Timeline Follow Back (TLFB) 
interviews by youth and parents separately. TLFB measures self-reported drug use, 
and a decreased number of days using drugs indicates a reduction of drug use. Azrin 
1994 combined the urine screens with reports on drug use type and frequency by the 
young person and parents at each session. 
 
Secondary outcomes 
 
Family functioning 
Azrin 2001 measured family functioning using the Parent Happiness with Youth 
Scale (PHYS) and Youth Happiness with Parents Scale (YHPS). PHYS and YHPS are 
measures developed from the Parent and Youth Satisfaction Scales used in Azrin 
1994. The PHYS measures parent’s degree of satisfaction with youth on a series of 
behavioral domains (Communication, Friends and activities, Curfew, Household 
rules, School, Response to rewards, Response to discipline, Chores, Alcohol use, 
Drug use, Illicit behavior) on a scale from 0-100%. The YHPS measures the young 
person’s satisfaction with parents on the same scale and over the same behavioral 
domains as the PHYS. 
 
In Azrin 1994, family functioning was measured using the Parent Satisfaction Scale 
and Youth Satisfaction Scale. The Parent Satisfaction Scale and the Youth 
Satisfaction Scale were used to measure the overall satisfaction of the parent-youth 
relationship on a scale from 0-100% by youth and parents. 
 
Education or vocational involvement 
 
Azrin 2001 reported on the school scale of the Child Behavior Checklist (CBCL) 
which is a measure of emotional and behavioural adjustment completed by teachers,  
and Azrin 1994 provides school or work attendance reported by youth and parents. 
Although Azrin 2001 further report on satisfaction in this domain by the school scale 
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in PHYS and the school aspect of the Life Satisfaction Scale for Adolescents (LSS-A) 
reported by the young person, educational measures in the two included studies are 
non-comparable.  
 
Retention 
 
Retention is unclear in Azrin 2001 and Azrin 1994, due to the lack of information on 
total number of participants randomized in the studies.   
 
Risk behavior 
 
Risk behavior is reported by arrests history records in Azrin 2001. Azrin 1994 
measures risk behavior by arrests reported by youth and parents. 
 
Other adverse effects 
 
There are no reports on other adverse effects in the included studies.  
 
Independence 
The two included studies are conducted by FBT program developer Nathan Azrin 
and the current Program Director Bradley Donohue (Azrin 1994, Azrin 2001). 
 
For further details on included studies see section 9.1 Characteristics of included 
studies.  
 
4.2.2 Excluded studies 
Studies without a control group 
Two studies were excluded because they did not have a control group (Bry, Conboy 
& Bisgay, 1986; Bry & Krinsley, 1992). 
 
Case studies 
Three case studies were excluded (Donohue & Azrin, 2002; Juhnke & Liles, 2000; 
Moncher, Holden, Schinke & Palleja, 1990). 
  
None of these five studies fulfilled our inclusion criteria and were therefore excluded 
from review (see section 8.2 and section 9.2). 
 
4.3  RISK OF BIAS IN INCLUDED STUDIES 
Neither of the two included studies can be characterized as a robust RCT as both had 
at least one assessed item judged to have a risk of bias greater than ‘low’. A key issue 
in regards to assessment of risk of bias in the two studies is the lack of information 
on the number of participants randomized in the trials.  
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The ratings of the two studies in relation to the nine domains in the Risk of Bias tool 
are listed below, and summarized in table 4.3. See section 9.3 for further details on 
risk of bias in included studies. The risk of bias judgments were based on pre-
specified questions and a 5 point scale with ratings of 1=low risk and 5=high risk 
(see section 10.2 Risk of Bias tool).  
 
Nathan Azrin was contacted for details on any uncertainties in relation to risk of bias 
assessment items, but unfortunately no response has been received. 
 
4.3.1 Sequence generation 
Both included studies were described as randomized controlled trials, with 
randomization reported as being at the level of the family. Azrin 2001 reported a 
procedure for randomization in matched pairs that was judged as having a low risk 
of bias for sequence generation. Azrin 1994 also reported randomization in matched 
pairs, although here there was a lack of clarity on how 14 participants who had 
participated in an earlier study were allocated in the current trial. The risk of bias for 
sequence generation in Azrin 1994 was therefore judged as ‘unclear’.  
 
4.3.2 Allocation concealment 
Both included studies randomized using the toss of a coin, and were judged as 
having a low risk of bias for allocation concealment.  
 
4.3.3 Blinding  
As is common in social interventions, especially when outcomes are self-reported, 
there is inherent bias given the impossibility of blinding participants or those 
delivering the interventions. Outcome assessors could be blind to participant’s group 
allocation, but only Azrin 2001 report that outcome assessors were blinded to 
participant’s treatment assignments, and is rated 1 for blinding. Azrin 1994 did not 
report on blinding and the risk of bias for this item was therefore assessed as unclear 
for this study. 
 
4.3.4  Incomplete outcome data 
Drop-outs were reported in both studies. Analysis is performed for attrition 
imbalance and only imbalance found in Azrin 2001 is a higher percentage of male 
primary caregivers for treatment completers. Azrin 1994 analyze potential 
imbalance in days of drug use prior to treatment for completers and non-completers, 
and find no imbalance in this measure.  
 
 40      The Campbell Collaboration | www.campbellcollaboration.org 
Both studies lack information on total number of participants randomized in the 
trials, which is obscuring the possibility to assess missing data. Both studies exclude 
participants from the analysis based on number of sessions attended.  
 
Azrin 2001 excludes participants with less than 8 sessions completed. Azrin 2001 
use mean substitution when data are missing from follow up measurements for all 
outcomes but Urine analysis and the school subscale of the CBCL (among those 
included in the analysis). Due to the lack of clarity on number of participants 
randomized and missing data Azrin 2001 is rated unclear risk of bias for incomplete 
outcome reporting.  
 
Azrin 1994 excludes participants who completed less than 4 sessions from the 
analysis. Azrin 1994 does not report details on dealing with missing data. Due to the 
lack of information on N’s randomized and missing data Azrin 1994 is rated unclear 
risk of bias for incomplete outcome reporting.  
 
4.3.5 Selective outcome reporting 
Both studies lack information on the total number of participants randomized in the 
trials, and the proportion of participants included in the analysis compared to those 
potentially missing from the analysis is therefore unknown. In Azrin 2001, only 
participants who completed 8 or more treatment sessions were included in analysis 
raising the possibility that a significant proportion of participants might have been 
excluded from the analysis. Azrin 2001 was therefore rated 4 for risk of bias related 
to selective outcome reporting.  
In Azrin 1994 participants were excluded from the analysis if they had not 
completed at least 4 sessions, raising the possibility that a proportion of participants 
are likely to be excluded from the analysis. Azrin 1994 was rated unclear for risk of 
bias related to selective outcome reporting.  
 
4.3.6  Other potential sources of bias 
We were not able to locate protocols for any of the two studies.  
 
Table 4.3 Risk of bias across included studies 
  Azrin et al., 2001 Azrin et al., 1994a 
Sequence generation Low Unclear 
Allocation concealment Low  Low 
Blinding 1 Unclear 
Incomplete outcome data Unclear Unclear 
Free of selective reporting 4 Unclear 
Free of other bias - - 
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A priori protocol Unclear Unclear 
A priori analysis plan Unclear Unclear 
Confounding NA NA 
NA: Not Applicable.  
 
4.4  EFFECTS OF THE INTERVENTIONS 
In the protocol for this review, the following comparisons/analysis were planned: 
- Absolute effects, comparing FBT to no treatment and untreated waitlist 
controls.  
- Relative effects, comparing FBT to other interventions and/or treatment as 
usual (TAU).  
 
The experimental intervention given to participants was manual based FBT in both 
included studies. Comparison conditions were Individual Cognitive Problem-Solving 
(ICPS) and Supportive Counseling.  No conclusion could therefore be drawn on the 
absolute effects of FBT.  
 
Meta-analysis was performed on the primary outcome, drug use reduction, and on 
the secondary outcomes family functioning and risk behavior. Meta-analysis was not 
feasible for the outcomes of education, retention or other adverse effects due to 
differences in outcome measures, or to lack of data.  
 
We grouped the outcomes of both studies at end of treatment. For drug use 
frequency, averaged scores over the course of the six months treatment period were 
used. Azrin 2001 additionally reported drug outcomes averaged over the six months 
period from end of treatment to 12 month post-intake. For family functioning, Azrin 
2001 interviewed at end of treatment and at 12 month post-intake, whereas Azrin 
1994 measured repeatedly during the six months of treatment; the outcome reported 
and grouped at end of treatment is an average score over the six months. For arrests 
(risk behavior),   
Azrin 2001 reported accumulated scores over the course of the six months treatment 
and accumulated scores over the six month post-treatment period, whereas Azrin 
1994 reported an average of the number of arrests per month over the six month 
treatment period.   
 
4.4.1 Primary outcome results 
The two included studies report drug use reduction in terms of number of days of 
drug use per month. For Azrin 2001, there was no statistically significant difference 
between FBT and the comparison treatment at end of treatment. For Azrin 1994, 
however, there was a statistically significant difference in favor of FBT at end of 
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treatment. Pooled results show no statistically significant effect of FBT on drug use 
reduction. The pooled estimate is SMD = 0.49 (95% CI -0.51, 1.50) with statistically 
significant heterogeneity between studies (p=0.04, Tau2=0.40, I2=75%).  
 
For Azrin 2001, there was no statistically significant difference between FBT and the 
comparison treatment at 12 months post-intake; SMD=-0.03 (95% CI -0.58, 0.52). 
 
 
 
Figure 4.1: Drug use reduction. End of treatment.  
 
 
Figure 4.2: Drug use reduction. 12 month post-intake 
 
 
4.4.2  Secondary outcomes results 
Family functioning 
Family functioning was reported using the Parent Happiness with Youth Scale 
(PHYS) and the Youth Happiness with Parents Scale (YHPS) in Azrin 2001, and the 
Parent and Youth Satisfaction Scales in Azrin 1994. In Azrin 1994, there was a 
statistically significant difference in parent satisfaction at the end of treatment 
favoring FBT, whereas no significant difference emerged in Azrin 2001 on this 
outcome. Pooled results for parent satisfaction show statistically significant effects 
of FBT on family functioning reported by parents; SMD= 0.58 (95% CI 0.02, 1.13) 
with no statistically significant heterogeneity between studies (p= 0.26; Tau2 = 0.04, 
I2=22%). Neither study demonstrated a statistically significant effect of FBT on 
youth satisfaction at end of treatment; pooled results were SMD= 0.29 (95% CI -
0.72, 1.30) with a statistically significant heterogeneity between studies (p=0.05, 
Tau2=0.40, I2=74%). For Azrin 2001 at 12 month post-intake, there was no 
statistically significant difference between FBT and the comparison treatment, for 
either parent satisfaction or youth satisfaction with family functioning; the SMD for 
parent satisfaction was -0.30 (95% CI -0.86, 0.26) and the youth was 0.47 (95% CI -
0.09, 1.04). 
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Figure 4.3: Family functioning, parent report. End of treatment. 
 
 
 
Figure 4.4: Family functioning, youth report. End of treatment 
 
 
 
 
Figure 4.5: Family functioning, parent report. 12 month post-intake 
 
 
 
Figure 4.6: Family functioning, youth report. 12 month post-intake 
 
 
 
Education or vocational involvement 
The measures for education and vocational outcome are not comparable between 
the two studies. Azrin 2001 uses the school subscale of the Child Behavior Checklist 
(CBCL). Azrin 1994 reported combined school and work attendance. At end of 
treatment there were no statistically significant differences found in either study; 
SMD=0.01 (95% CI -0.63, 0.66) and SMD=-0.11 (95% CI -0.90, 0.68). For Azrin 
2001, there was no statistically significant difference at 12 month post-intake; SMD= 
0.31 (95% CI -0.45, 1.07) 
 44      The Campbell Collaboration | www.campbellcollaboration.org 
Figure 4.7: Education or vocational involvement, Child Behavior Checklist (CBCL) 
and combined school and work attendance (CSWA). End of treatment. 
 
 
Figure 4.8: Education or vocational involvement, Child Behavior Checklist (CBCL). 
12 month post-intake. 
 
 
Retention 
It was not possible to perform meta-analysis on retention because no information 
was available in either study on the number of participants randomized. 
 
Risk behavior 
Both studies provided delinquency measures in terms of the number of arrests. No 
statistically significant effect emerged in either study. Pooled results show no 
statistically significant effect for FBT on arrests; SMD= 0.29 (95% CI -0.16, 0.74) 
with no statistically significant heterogeneity between studies (p= 0.60, Tau2= 0.00, 
I2=0%). For Azrin 2001, however, there was a statistically significant difference 
favoring the comparison treatment at 12 months post-intake; SMD= -0.56 (95% CI -
1.13, 0.00). 
 
 
 
Figure 4.9: Risk behavior, arrests. End of treatment. 
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Figure 4.10: Risk behavior, arrests. 12 month post-intake. 
 
 
Other adverse effects 
No other adverse effects (as measured, for example, by rates of hospitalization, 
suicide and overdoses) were reported in the two included studies.  
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5 Discussion  
5.1  SUMMARY OF THE MAIN RESULTS 
Two randomized controlled trials of FBT met the inclusion criteria for this review. It 
was not possible to analyze the absolute effects of FBT. Both studies compared FBT 
to other active interventions, namely Individual Cognitive Problem Solving (ICPS) 
and Supportive counseling.  
 
The outcomes were reported at varying time points. We grouped the outcomes at 6 
months post randomization, which corresponds to the end of treatment for all 
treatment conditions. Only one study reported outcomes at 12 month post-intake. 
 
Our main objective was to evaluate the current evidence on the effect of FBT on drug 
use reduction for young people in treatment for non-opioid drug use. Further 
objectives were to examine the moderators of drug use reduction effects and to 
examine if FBT works better for particular groups, although it was not possible to 
assess these due to the limited number of studies.  
 
When interpreting the results, consideration should be given to the limited number 
of studies included in the analysis and to the limited number of participants 
included in those two studies. The conclusions that can be drawn from providing 
FBT to young drug users compared to other active treatments would be more 
convincing if more studies were available.  
 
To summarize on the main objective, we found the following results: 
 
Abstinence or reduction of drug use 
Meta-analysis of the two included studies (Azrin 2001, Azrin 1994) did not show a 
statistically significant effect of FBT for youth drug use reduction at end of treatment 
and there was no statistically significant difference for Azrin 2001 at 12 month post-
intake. . Thus available data does not support the hypothesis that there is a drug use 
reduction effect of giving FBT to young drug users compared to Individual Cognitive 
Problem-Solving (ICPS) and supportive counseling (SC).   
 
Family functioning 
Meta-analysis of the two included studies showed a statistically significant effect of 
FBT on family functioning as reported by parents compared to ICPS and SC, 
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although the confidence intervals are wide. Meta-analysis of family functioning 
reported by youth did not show any statistically significant effect of FBT compared 
to ICPS and SC. At 12 month post-intake, effect sizes for family functioning (as 
reported by parent or youth) were not statistically significant.  
 
Education or vocational involvement 
It was not possible to perform meta-analysis on the outcomes of education or 
vocational involvement as the measures used in the two studies were not 
comparable. Neither of the studies reported any statistically significant effect on 
school outcomes for FBT compared to ICPS and SC. 
 
Retention 
It was not possible to perform meta-analysis on retention due to lack of data.  
 
Risk behavior 
Meta-analysis of the two studies showed no statistically significant effect for FBT on 
arrests in comparison to ICPS and SC. At 12 month post-intake, however, Azrin 2001 
showed a statistically effect favoring the comparison treatment ICPS. There is no 
evidence of any significant difference between FBT and comparison treatments on 
arrests at the end of treatment, and there is indication of an effect favoring the 
comparison treatment at 12 month post-intake.  
 
Other adverse effects 
No other adverse effects (as measured by, for example, rates of hospitalization, 
suicide and overdoses) were reported in the included studies.  
 
In conclusion, the few available studies preclude any firm conclusions being drawn 
on the effectiveness, ineffectiveness or potential damage of FBT for young people in 
treatment for non-opioid drug use.  
 
5.2  OVERALL COMPLETENESS AND APPLICABILITY OF 
EVIDENCE 
We found only two trials that examined whether FBT reduce youth drug use; both 
studies include outpatient manual based FBT intervention. Both were performed in 
the US by the FBT program developer. It was not possible to analyze the absolute 
effects of FBT. Both studies compared FBT to other active treatments. The majority 
of participants in the two included studies were male (77% and 82 % respectively). 
 
It was only possible to pool outcomes at 6 months post baseline, which equates to 
the end of treatment. Only one of the two studies provided follow up at 12 months 
post baseline, allowing for documentation of accumulated or longer-term effects. 
Thus there is the possibility that the follow up period is insufficient for significant 
changes to be detected.  
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Both studies provide data on the primary outcome reduction of drug use. Data on 
secondary outcomes are reported. However, the data provided on education and 
retention is non-comparable or inconsistent.  
 
5.3  QUALITY OF THE EVIDENCE 
Both included studies are randomized controlled trials. However, neither can be 
characterized as a robust RCT with a low risk of bias on all assessed items. The two 
included studies provide insufficient information on core issues to allow us to assess 
the risk of bias (e.g. number of participants randomized) despite genuine efforts to 
contact study authors. These methodological weaknesses may reflect inadequate 
reporting, flawed methodology, or both, and therefore compromise our confidence 
in the validity of the two studies.  
 
5.4  POTENTIAL BIASES IN THE REVIEW PROCESS 
The narrow search strategy performed in this review may have limited the likelihood 
of finding relevant studies. However, we attempted to minimize the risk of missing 
relevant studies by conducting an extensive search of the grey literature, by 
extensive hand searching, and by contacting international experts within the field of 
FBT. Indeed the large number of records from the grey literature and the hand 
searches that has been assessed for relevance attests to this effort.  
 
5.5  AGREEMENTS AND DISAGREEMENTS WITH OTHER 
STUDIES OR REVIEWS 
We identified five narrative reviews and four quantitative reviews on FBT treatment 
for drug using youth. All but one of these reviews base their FBT findings on one of 
the two FBT trials included in this review (Azrin 2001 or Azrin 1994).  
 
All five narrative reviews review several interventions for drug-using youth. Four of 
the five (Austin et al., 2005; Williams et al., 2000; Deas & Thomas, 2001; Hogue & 
Liddle, 2009) report a general pattern of positive effects of FBT. Three of the five 
base their conclusions on the effects of FBT solely on Azrin 1994 (Austin et al., 2005; 
Williams et al., 2000; Deas & Thomas, 2001), and one is based solely on Azrin 2001 
(Hogue & Liddle, 2009). Consistent with our findings, the narrative reviews also 
conclude that more research is needed. One review, Becker & Curry (2008), 
examines the quality of evidence in trials on outpatient interventions for youth 
substance use, and rates the quality of the trials on FBT (Azrin 1994 and Azrin 2001) 
as methodologically weaker.  
 
 49      The Campbell Collaboration | www.campbellcollaboration.org 
We identified four quantitative reviews (Bender, Tripodi, Sarteschi & Vaughn, 2011; 
Vaughn & Howard, 2004; Bender, Springer & Kim, 2006; Waldron & Turner, 2008). 
Bender et al., 2011 and Vaughn & Howard, 2004 reviewed several interventions for 
drug using youth; their conclusions regarding FBT are based on one study, Azrin 
1994. Based on this study, FBT is described by Vaughn & Howard, 2004 (p. 334) as 
“Evidence of clinically meaningful effect (ES > .20) with relatively strong designs 
and less than 1-year follow-up and no replication”. Bender et al., 2011 used meta-
analysis to evaluate family therapy and individual therapy for drug-using youth, and 
found that FBT yielded large effects (> .80), again based solely on Azrin 1994.  
Waldron & Turner, 2008 used meta-analysis to evaluate family therapy, CBT 
(individual and group) and ‘minimal treatment control conditions’ for drug-using 
youth. The conclusion from Waldron & Turner (2008) is that “Other family models, 
including MST, BSFT and BFT [FBT, red.], are probably efficacious, pending 
replication by independent research teams.” (p. 255), based on the Azrin 2001 
study.  
 
Finally, Bender et al., 2006 reviewed treatment effectiveness of several interventions 
for dually diagnosed adolescents by examining between-group effect sizes and 
within-group changes. Their conclusions regarding FBT are based on Azrin 2001 
only, and are summarized by the authors as “a small treatment effect favoring the 
FBT group” for the reduction of substance use (Bender et al., 2006 p. 192).  
 
Consistent with our expectations, the majority of these reviews conclude that more 
research is needed on the effects of FBT, on possible moderators of that effect, on 
identification of which subgroups of youth may be more likely to respond to specific 
interventions, and on how treatments can be adapted or tailored to the individual 
needs of youth to improve drug use outcomes. These are similar to the issues we had 
planned to assess in our review. However, the lack of empirical evidence obscured 
the possibility of assessing the effects of FBT, any moderators of that effect, and the 
effects on subgroups. 
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6 Authors’ Conclusion  
6.1  IMPLICATIONS FOR PRACTICE 
We are unable to draw firm conclusions on the effects of FBT, and so the review does 
not have implications for practice.  
 
6.2  IMPLICATIONS FOR RESEARCH 
Research in the field of treatment for young drug users is challenging to conduct, 
and available studies reflect the challenges in the field. There are a very modest 
number of controlled evaluations of treatment for drug-using youth, and most of the 
few available studies have methodological problems such as small sample sizes with 
insufficient power to test for differences between treatment groups, and the use of a 
variety of methods to assess drug use. Such problems make definitive conclusions 
difficult if not impossible. Thus, there is not only a need for more research, but a 
need for clear methodological attributes to be incorporated in the design of future 
studies in order to improve the evidence base for drug use treatments for young drug 
users.  
 
Only evidence about the relative effects of FBT is available. Evidence about the 
absolute effect could be achieved if future studies were to incorporate a waitlist 
control condition, for example. 
 
There is also a need for more uniform reporting in the publications generated by 
outcome studies. If adherence to the CONSORT 2010 statement was required by a 
broader array of journals, we believe this would promote more uniform reporting 
and stronger methodological quality across disciplines.  
 
Finally, it is also important to consider the possibility of any adverse effects these 
interventions might have. The popular belief is that FBT, as well as other family 
therapy approaches, is harmless, but there has actually been very little research 
conducted that focuses on the potential harm of such family therapy approaches. 
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9 Characteristics of studies  
9.1  CHARACTERISTICS OF INCLUDED STUDIES 
Azrin et al., 2001  
Methods Design: RCT (2 intervention arms) total n= 88 
Participants  Age: 12-17 years, mean age 15.4. 
Gender:  82% male 
Ethnicity:  21% ethnic minority. 
Family status: 25% of participants are living in single parent families. Median gross 
family income per year was  $44,000. 77% of participants were previously arrested. 
40% were enrolled in special education programs. 
Main drug of use:  Cannabis.  
Severity: All youth had used marijuana at least once, and most had used alcohol or 
hard drugs (illicit drugs other than marijuana). Youths estimates of their total number 
of days using substances in their lifetime are 385 for marijuana.  
Comorbidity:  76% dual diagnose of substance use/dependency and conduct 
disorder. A great percentage in addition to the conduct disorder and substance use 
diagnoses, received ADHD or Dysthymia diagnosis. 
Inclusion criteria:  Age 12-17, symptoms consistent with DSM-V diagnosis of conduct 
disorder plus substance abuse/dependency, live with parent, live within 30 mins. of 
clinic, no diagnosis of mental retardation or psychotic disorder, not receiving 
psychological intervention, at least 1 parent will provide transport and participate in 
treatment. 
Exclusion criteria: Not reported 
Interventions Intervention: Manual based FBT. Baseline n not reported, treatment completers = 29 
Youth and parents attend sessions together and separately, and perform 
assessments and ratings together and individually.  
Duration: 15 sessions delivered over 6 months. Sessions once per week for first 3 
months, decreasing to every other week, and eventually to once per month. 90 
minutes sessions initially, decreasing to 60-75 minutes from the seventh to fifteenth 
session. Average number of sessions attended for FBT is 13.48. 
Location: Transportation required so no home location. Florida, US. 
 
Comparisons: Manual based Individual Cognitive Problem-Solving (ICPS). Baseline n 
not reported. Treatment completers = 27.  
15 sessions delivered over 6 months. Sessions once per week for first 3 months, 
decreasing to every other week, and eventually to once per month. 90 minutes 
sessions initially, decreasing to 60-75 minutes from the seventh to fifteenth session. 
Average number of sessions attended for ICPS 13.70. 
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Relevant 
Outcomes 
 
 
Baseline 
6 mths post 
BL 
12 months 
post BL 
Primary outcomes: Youth drug use.  
Measures: Days of drug use per month measured by a combination of Urine Drug 
Screens and  Timeline Follow Back (TLFB). Percent abstinent based on urine 
analysis only. 
 
 
Secondary outcomes: Family functioning, education and risk behavior.  
Measures: Family functioning measured by Parent Happiness with Youth Scale and 
Youth Happiness with Parents Scale. Education measured by Child Behavior 
Checklist, and satisfaction in this domain by Parent Happiness with Youth Scale 
school and Life Satisfaction Scale school. Risk behavior measured by arrest history 
records, Youth Self Report delinquency and Child Behavior Checklist delinquency.  
Notes  
Azrin et al., 1994a  
Methods Design: RCT (2 intervention arms) total n= 29  
Participants  Age: 13-18, mean age 16.0 years. 
Gender: 77% male.  
Ethnicity: 19% minority background. 
Family status: Not Reported. Youth mean education 9.5 years. 19% school drop outs. 
Main drug of use: Cannabis.  
Severity: 96% marijuana users, 35% cocaine users, 31% LSD users, 4% 
methamphetamine user, 4% benzodiazipine user 
Comorbidity:  Not reported. 
Inclusion criteria:  1. age 18 or younger and had engaged in illegal drug use other 
than, or in addition to, alcohol use, during past month, 2. not receiving 
psychological/psychiatric treatment, 3. resided within 12 miles of the counselling 
centre, 4. resided locally for the past 6 months and no moving plans outside local 
area, 5. completed 4 or more treatment sessions, 6. willing to provide drug use data 
for 6 months following initiation of treatment.. 
Exclusion criteria:   Not Reported. 
Interventions Intervention: Manual based Family Behavior Therapy.  n=15. 
Parents attended all sessions.  
Duration:  6 months, twice weekly during initial stages of treatment, and then reduced 
in frequency when progress was apparent. Mean 15 two hour sessions.  
Location: Not Reported. 
 
Comparisons: Supportive counseling. n=14 
Designed to include principal features of supportive counseling, emphasizing 
expression of feeling, self-attempts at insight, discussion of drug related experiences 
and feelings, and group interaction, with no specific directives by the counselor. Youth 
attended individual sessions, parents attended sessions once per month. 6 months 
duration, mean 15 sessions. One hour sessions weekly for individual counseling, 2 
hour sessions for group counseling. 
Relevant 
Outcomes 
 
 
 
Baseline 
Primary outcomes: Adolescent drug use.  
Measures: Urine Drug Screens, youth self-report and parent report. Urine samples 
collected at all sessions, 1 monthly sample underwent a broad screen assay for all 
commonly used drugs by the National Health Labs. Days per month of drug use 
based on a combination of urine analysis, self-report and parent report. Months of 
drug use based on a combination of urine analysis, self, or parent report and based 
on urine analysis only. 
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6mth from 
BL  
 
  
Secondary outcomes: Family functioning, education and risk behavior. 
Measures: Family functioning measured by Parent Satisfaction Scale and Youth 
Satisfaction Scale. Education measured by school or work attendance. Risk behavior 
measured by arrests and institutionalization.  
Notes  
 
 
9.2  CHARACTERISTICS OF EXCLUDED STUDIES 
 
Study Reason for exclusion 
Bry et. al (1986) Study without a control group 
Bry et. al (1992) Study without a control group 
Donohue et. al (2002) Case study 
Juhnke et. al (2000) Case study 
Moncher et. al (1990) Case study 
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9.3  RISK OF BIAS FOR INDIVIDUAL INCLUDED STUDIES 
 
 
Azrin et al. 2001 
 
DIMENSION  ITEM 
 
ASSESSMENT 
 
DESCRIPTION 
SEQUENCE 
GENERATION  
 
Adequate sequence 
generation? 
Low Risk of 
Bias 
Attempts were made to match participants 
based on age, days of monthly drug use, 
types of drugs used, and the Problem and 
Intensity scales of the ECBI. When two or 
more participants were available for 
assignment, they were matched on the 
aforementioned variables; one participant 
was assigned by coin toss to one of the 
treatment conditions, and the other person 
was assigned to the other treatment 
condition. If an appropriate match was not 
available for a participant by the end of the 
baseline period (i.e., app 4 weeks after the 
initial assessment sessions was conducted), 
the participant was randomly assigned by 
coin toss. 178 participants met inclusion 
criteria, and 88 attended 3 assessment 
sessions and completed at least 1 treatment 
session. However, it remains unclear how 
many participants were randomized.  
ALLOCATION 
CONCEALMENT 
Allocation concealed? Low Risk of 
Bias 
 
BLINDING Blinding of outcome 
assessors? 
1 The persons who administered the post and 
follow-up assessments were blind, 
independent assessors who were not aware 
of the participants’ treatment assignment, 
nor were these assessors involved in the 
treatment program. 
INCOMPLETE 
OUTCOME 
DATA 
Drop-outs reported? Unclear Risk of 
Bias 
Drop-outs were reported.  
Analysis for difference 
between prop-outs and 
completers? 
Analysis of demographic characteristics 
revealed no difference between treatment 
completers and treatment non-completers, 
apart from treatment completers had more 
male primary caregivers.  
Missing data reported? Missing data is unclear since the article 
does not provide the total number of 
participants randomized.  Analysis included 
only participants who completed 8 or more 
sessions. Awaiting response from author.  
Missing data dealt with? For outcomes based on Urine analysis and 
the school subscale of the CBCL missing 
data was not dealt with.  
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For all other outcomes; When missing data 
were present, series mean substitution was 
utilized.  
SELECTIVE 
OUTCOME  
REPORTING 
Free of selective and/or 
incomplete outcome 
reporting? 
4 Since the study does not provide the total 
number of participants randomized we do 
not know the proportion of participants 
included in the analysis compared to those 
potentially missing from the analysis. Only 
participants who completed 8 or more 
treatment sessions were included in 
analysis. A large proportion of treatment 
participants are excluded from the analysis 
for not having completed minimum 8 
sessions. Awaiting response from author. 
OTHER 
POTENTIAL 
THREATS TO 
VALIDITY 
Free of other potential 
threat to validity? 
-   
A PRIORI 
PROTOCOL 
 
Is there an a  priori 
protocol (and was it 
followed)? 
Unclear Risk of 
Bias 
Not reported. Awaiting response from 
author.  
A PRIORI 
ANALYSIS 
PLAN 
Is there an a priori 
analysis plan (and was it 
followed)? 
Unclear Risk of 
Bias 
Not reported. Awaiting response from 
author. 
 
 
Azrin et al. 1994a 
 
DIMENSION  ITEM 
 
ASSESSMENT 
 
DESCRIPTION 
SEQUENCE 
GENERATION  
 
Adequate sequence 
generation? 
Unclear Risk of 
Bias 
Families were randomized into groups by 
coin toss in matched pairs (as described in 
Azrin et al. 1994b, p. 858).  
When 2 youth were concurrently available 
for assignment to condition, the coin flip 
determined which one was assigned to the 
behavioral treatment, the other being 
assigned to the supportive treatment if a 
match was available. When no match was 
available at the end of the baseline period, 
the participant was randomly assigned by 
coin toss.  
 
Despite the adequate sequence generation 
described above, the study is judged with 
unclear Risk of Bias for sequence 
generation due to the following: 14 
participants had been used in a previous 
trial and it is unclear how they were 
allocated in this trial. Awaiting author reply.   
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ALLOCATION 
CONCEALMENT 
Allocation concealed? 
 
Low Risk of 
Bias 
Coin toss is not potentially predictable.  
BLINDING Blinding of outcome 
assessors? 
Unclear Risk of 
Bias 
Not reported. Awaiting response from 
author.  
INCOMPLETE 
OUTCOME 
DATA 
  
 
Drop-outs reported? Unclear Risk of 
Bias 
Dropouts were reported 
Analysis for difference 
between prop-outs and 
completers? 
Analysis on days of drug use pre-treatment 
for dropout/completers show no statistical 
difference.  
 
Missing data reported? Missing data is unclear since the article 
does not provide the total number of 
participants randomized.  Analysis included 
only participants who completed 4 or more 
sessions. Awaiting response from author. 
Missing data dealt with? No 
SELECTIVE 
OUTCOME  
REPORTING 
 
 
Free of selective and/or 
incomplete  outcome 
reporting? 
 
 
Unclear Risk of 
Bias 
Since the study does not provide the total 
number of participants randomized we do 
not know the proportion of participants 
included in the analysis compared to those 
potentially missing from the analysis.  
OTHER 
POTENTIAL 
THREATS TO 
VALIDITY 
Free of other potential 
threat to validity? 
-   
 
A PRIORI 
PROTOCOL 
 
Is there an a  priori 
protocol (and was it 
followed)? 
Unclear Risk of 
Bias 
Not reported. Awaiting response from 
author.  
A PRIORI 
ANALYSIS 
PLAN 
Is there an a priori 
analysis plan (and was it 
followed)? 
Unclear Risk of 
Bias 
Not reported. Awaiting response from 
author. 
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10 Appendices 
10.1  SEARCH HISTORIES FROM THE BIBLIOGRAPHIC 
DATABASES 
 
PsycINFO Ovid 1806 to June Week 2 2011  
  
(FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.   369  
 
PsycINFO Ovid 1806 to October 2014  
  
(FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.   217  
 
 
 
MEDLINE(R) Ovid 1948 to June Week 2 2011  
 
(FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.    339  
 
MEDLINE(R) Ovid 1948 to October 2014  
 
(FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.    79  
 
 
 
Embase Ovid 1980 to 2011 Week 24  
 
FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.    891 
 
Embase Ovid 1980 to October 2014 
 
FBT or BFT or (Famil* adj1 Behavio$r* adj1 therap*)).af.    175 
 
 
 
SocIndex  search history Tuesday, May 17 
 
S1 TX FBT or TX BFT or TX Famil* n1 Behavio#r* n1 therap*                        1747 
 
SocIndex  search history October 2014 
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S1 TX FBT or TX BFT or TX Famil* n1 Behavio#r* n1 therap*                        109 
 
 
 
Social Care Online search history May  2011 
 
freetext="Famil* Behavio*  therap*" or freetext="FBT" or  freetext="BFT"    7 
 
Social Care Online search history October 17 
 
freetext="Famil* Behavio*  therap*" or freetext="FBT" or  freetext="BFT"    5 
 
 
 
Libris search History 10-06-2011 
 
FBT OR BFT or  Famil* Behavio* Therap*   240 
 
Libris search History October 2014 
 
FBT OR BFT or Famil* Behavio* Therap*   63 
 
 
 
ERIC search history Tuesday, May 2011 
 
S1 TX FBT or TX BFT or  TX Famil* n1 Behavio#r* n1 therap*  362 
 
ERIC search history  October 2014 
 
S1 TX FBT or TX BFT or  TX Famil* n1 Behavio#r* n1 therap*  31 
 
 
 
Cochrane search History 10-06-2011 
 
#1 FBT or BFT or Famil* near/1 Behavio* near/1 Therap*   36 
 
Cochrane search History October 2014 
 
#1 FBT or BFT or Famil* near/1 Behavio* near/1 Therap*  30                                      
 
 
 
CJA search history Tuesday, May 2011 
 
S1 TX FBT or TX BFT or TX Famil* n1 Behavio#r* n1 therap*   33 
base – Criminal Justice Abstract 
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CJA search history Tuesday, October 2014 
 
S1 TX FBT or TX BFT or TX Famil* n1 Behavio#r* n1 therap*    
base – Criminal Justice Abstract    11 
 
 
Cinahl search history Tuesday, May 2011 
 
S1 TX FBT or TX BFT or TX Famil* n1 Behavio#r* n1 therap*   263 
 
 
 
Science citation abstract May 18, 2011  
  1       833 
Topic=(Famil* same Behavio$r* same session*) OR Topic=(Famil* same 
Behavio$r* same Therap?*) OR Topic=(fbt) OR Topic=(bft) 
Databases=SCI-EXPANDED Timespan=All Years   
 
Science citation abstract May 18, 2011  
  1       106  
Topic=(Famil* same Behavio$r* same session*) OR Topic=(Famil* same 
Behavio$r* same Therap?*) OR Topic=(fbt) OR Topic=(bft) 
Databases=SCI-EXPANDED Timespan=All Years   
 
 
  
Social Science citation abstract  May 18 
1       859  
Topic=(Famil* same Behavio$r* same session*) OR Topic=(Famil* same 
Behavio$r* same Therap?*) OR Topic=(fbt) OR Topic=(bft) 
Databases=SSCI Timespan=All Years   
 
Social Science citation abstract  May 18 
1       82  
Topic=(Famil* same Behavio$r* same session*) OR Topic=(Famil* same 
Behavio$r* same Therap?*) OR Topic=(fbt) OR Topic=(bft) 
Databases=SSCI Timespan=All Years   
  
 
 
Bibliotek.dk search History October 2014 
 
FBT OR BFT or Famil* Behavio* Therap*   99 
 
Bibliotek.dk search History October 2014 
 
FBT OR BFT or Famil* Behavio* Therap*   28 
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BIBSYS search History June, 2011 
 
FBT OR BFT or  Famil* Behavio* Therap*   332 
 
BIBSYS  search History October 2014 
 
FBT OR BFT or Famil* Behavio* Therap*   74 
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10.2  CODE BOOK FOR DATA EXTRACTION 
Author Study x 
Year   
Country  
Is this study about an FBT intervention evaluation?  
Are the participants 11 - 21 years of age?   
Are the participants in outpatient drug treatment for 
illicit non-opioid drug use? 
 
Is the report a  
…P=Primary study  
RE=Review  (Effect/meta-analysis) 
RD=Review (Descriptive)  
D=Descriptive 
T=Theoretical paper 
O=Other 
 
Is the study a RCT with a control group?  
Is the study a non-randomized controlled study with 
a control group? 
 
 Is the study..  
Notes  
State reason if necessary for excluded or uncertain.   
If lack of info., state question(s) to be sent to study 
authors. 
 
Objectives of the study  
 How many separate sites/facilities are included in 
the study? 
 
If RCT, was random assignment performed in the 
same way in all sites? 
 
List all the treatment groups in the study  
Were there any implementation differences between 
groups? 
 
Location of treatment  
 Location details   
If multiple sites, were there any implementation 
differences between sites?  
 
Was participant inclusion criteria mentioned?  
If yes describe.  
 Was participant exclusion criteria mentioned?  
If yes describe.  
Describe how the participants were referred to the 
intervention. 
 
Is the intervention mandated?   
If yes by whom and how many?   
Gender (e.g. % male)  
Age (details on age as presented in the study    
Race/ ethnicity   
Socioeconomic status  
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Family composition  
Other characteristics   
Specify the main drug  
Provide short description of the distribution of drug 
use 
 
List/describe history/severity of drug use  
List any co-morbid condition  
Report total of participants randomized  
 
Intervention   
Name the intervention  
How is the intervention delivered?   
If Family, Other or Combination, describe the way it 
is delivered 
 
Describe any practical circumstances relevant to the 
intervention 
 
If deviation from manual, describe/list the 
components given in the intervention   
 
Describe any co-interventions given with the 
intervention 
 
Frequency of the intervention   
Intensity  
Duration of the intervention    
Who delivered the intervention ?  
List program delivers qualifications.  
List program delivers characteristics.  
Describe methods used to ensure adherence to the 
intervention - specific to the the intervention 
 
What did the investigators do to check/measure 
treatment fidelity? 
 
Other important information  
 
Control group   
Name the control/comparison condition intervention?  
How is the control intervention delivered?   
If Family, Other or Combination, describe the way it 
is delivered. 
 
Describe any practical circumstances relevant to the 
intervention. 
 
If deviation from manual, describe/list the 
components given in the intervention   
 
Describe any co-interventions given with the 
comparison intervention 
 
Frequency of the intervention   
Intensity  
Duration of the intervention    
Who delivered the intervention?  
List program delivers qualifications.  
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List program delivers characteristics.  
Describe methods used to ensure adherence to the 
intervention. 
 
What did the investigators do to check/measure 
treatment fidelity? 
 
Did they measure session attendance?  
Other important information  
 
    
Baseline time - describe how baseline is defined.  
End of treatment (from baseline time)  
...1st follow-up  
..2nd follow-up  
..3rd follow-up  
..Other  
Author's main conclusion  
Limitations of the study as reported by the study 
authors 
 
Researchers affiliation with program  
Your own concerns and notes   
Question for review authors   
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10.3  RISK OF BIAS TOOL 
 
Risk of bias table 
 
Item Judgementa Description (quote from 
paper, or describe key 
information) 
1. Sequence generation 
  
2. Allocation concealment 
  
3. Confoundingb,       
  
4. Blinding?b                   
  
5. Incomplete outcome data 
addressed?b 
  
6. Free of selective reporting?b 
  
7. Free of other bias? 
  
8. A priori protocol?d 
  
9. A priori analysis plan?e 
  
 
a Some items on low/high risk/unclear scale (double-line border), some on 5 
point scale/unclear (single line border), some on yes/no/unclear scale (dashed 
border). For all items, record “unclear” if inadequate reporting prevents a 
judgement being made. 
b For each outcome in the study.  
c This item is is based on list of confounders considered important at the outset 
and defined in the protocol for the review (assessment against worksheet).  
d Did the researchers write a protocol defining the study population, intervention 
and comparator, primary and other outcomes, data collection methods, etc. in 
advance of starting the study? 
e Did the researchers have an analysis plan defining the primary and other 
outcomes, statistical methods, subgroup analyses, etc. in advance of starting 
the study? 
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Risk of bias tool 
 
Studies for which RoB tool is intended 
The risk of bias model is developed by Prof. Barnaby Reeves in association with the 
Cochrane Non-Randomised Studies Methods Group.10 This model, an extension of 
the Cochrane Collaboration’s risk of bias tool, covers both risk of bias in randomised 
controlled trials (RCTs and QRCTs), but also risk of bias in non-randomised studies 
(in this case non-randomised controlled trials NRCTs).   
The point of departure for the risk of bias model is the Cochrane Handbook for 
Systematic Reviews of interventions (Higgins & Green, 2008). The existing 
Cochrane risk of bias tool needs elaboration when assessing non-randomised studies 
because, for non-randomised studies, particular attention should be paid to 
selection bias / risk of confounding.   
 
 
Assessment of risk of bias 
Issues when using modified RoB tool to assess included non-randomised studies: 
 Use existing principle: score judgment and provide information (preferably 
direct quote) to support judgment 
 Additional item on confounding used for RCTs and NRCTs. 
 5-point scale for some items (distinguish “unclear” from intermediate risk of 
bias). 
 Keep in mind the general philosophy – assessment is not about whether 
researchers could have done better but about risk of bias; the assessment tool 
must be used in a standard way whatever the difficulty / circumstances of 
investigating the research question of interest and whatever the study design 
used. 
 Anchors: “1/No/low risk” of bias should correspond to a high quality RCT. 
“5/high risk” of bias should correspond to a risk of bias that means the 
findings should not be considered (too risky, too much bias, more likely to 
mislead than inform) 
 
1. Sequence generation 
 Low/high/unclear RoB item 
 Always high RoB (not random) for a non-randomised study 
 Might argue that this item redundant for NRS since always high – but 
important to include in RoB table (‘level playing field’ argument) 
 
2. Allocation concealment 
 Low/high/unclear RoB item 
 Potentially low RoB for a non-randomised study, e.g. quasi-randomised (so 
high RoB to sequence generation) but concealed (reviewer judges that the 
people making decisions about including participants didn’t know how 
allocation was being done, e.g. odd/even date of birth/hospital number) 
 
3. RoB from confounding ( assess for each outcome) 
 Assumes a pre-specified list of potential confounders defined in the protocol 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o  proportion of confounders (from pre-specified list) that were 
considered 
                                                        
10 This risk of bias model was introduced by Prof. Reeves at a workshop on risk of bias in non-randomised studies at 
SFI Campbell, February 2011. The model is a further development of work carried out in the Cochrane Non-
Randomised Studies Method Group (NRSMG). 
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o whether most important confounders (from pre-specified list) were 
considered 
o resolution/precision with which confounders were measured 
o extent of imbalance between groups at baseline 
o care with which adjustment was done (typically a judgment about the 
statistical modeling carried out by authors) 
 Low RoB requires that all important confounders are balanced at baseline 
(not primarily/not only a statistical judgment OR measured ‘well’ and 
‘carefully’ controlled for in the analysis. 
 
Assess against pre-specified worksheet. Reviewers will make a RoB judgment about 
each factor first and then ‘eyeball’ these for the judgment RoB table. 
 
4. RoB from lack of blinding (assess for each outcome, as per existing RoB tool) 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o nature of outcome (subjective / objective; source of information) 
o who was / was not blinded and the risk that those who were not 
blinded could introduce performance or detection bias 
o see Ch.8 
 
5. RoB from incomplete outcome data (assess for each outcome, as per existing RoB 
tool) 
 Low(1) / 2 / 3 / 4 / high(5) / unclear RoB item 
 Judgment needs to factor in: 
o reasons for missing data 
o whether amount of missing data balanced across groups, with similar 
reasons 
o see Ch.8 
 
6. RoB from selective reporting (assess for each outcome, NB different to existing 
Ch.8 recommendation) 
 Low(1) / 2 / 3 / 4 / high(5) /unclear RoB item 
 Judgment needs to factor in: 
o existing RoB guidance on selective outcome reporting 
o see Ch.8 
o also, extent to which analyses (and potentially other choices) could 
have been manipulated to bias the findings reported, e.g. choice of 
method of model fitting, potential confounders considered / included    
o look for evidence that there was a protocol in advance of doing any 
analysis / obtaining the data (difficult unless explicitly reported); 
NRS very different from RCTs. RCTs must have a protocol in advance 
of starting to recruit (for REC/IRB/other regulatory approval); NRS 
need not (especially older studies) 
o Hence, separate yes/no items asking reviewers whether they think 
the researchers had a pre-specified protocol and analysis plan. 
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Confounding Worksheet 
Assessment of how researchers dealt with confounding  
Method for identifying relevant confounders described by researchers:                          yes 
                                                                                                                                                            no                                                                                                                            
If yes, describe the method used: 
 
 
Relevant confounders described:                                                                                               yes 
                                                                                                                                                            no 
List confounders described on next page 
 
Method used for controlling for confounding 
At design stage (e.g. matching, regression discontinuity, instrument variable):  
………………………………………………..      
………………………………………………..  
………………………………………………..            
 
At analysis stage (e.g. stratification, multivariate regression, difference-indifference):    
………………………………………………..      
………………………………………………..  
………………………………………………..            
 
 
Describe confounders controlled for below 
 
 
Confounders described by researchers 
Tick (yes[0]/no[1] judgment) if confounder considered by the researchers [Cons’d?] 
Score (1[good precision] to 5[poor precision]) precision with which confounder measured 
Score (1[balanced] to 5[major imbalance]) imbalance between groups 
Score (1[very careful] to 5[not at all careful]) care with which adjustment for confounder was carried 
out 
 
Confounder Considered Precision Imbalance Adjustment 
Gender     
Age     
History of drug use      
Other      
Other:     
Other:     
 
 76      The Campbell Collaboration | www.campbellcollaboration.org 
11 Figures 
11.1  FLOWCHART FBT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Database literature 
 
SocIndex 1,856 
Eric 393 
SSCI 941 
SCI 939 
Criminal Justice 
Abstract 
44 
Cinahl 263 
Social Care Online 12 
PsycInfo 586 
Cochrane 66 
Medline 
Embase 
Bibliotek.dk 
Libris 
Bibsys 
418 
1,066 
127 
303 
406 
 
Total 7,420 
 
Grey literature 
 
Dissertation 
Google 
Google scholar 
Governmental sites 
Multi-disciplinary sites 
Subject specific sites 
78 
280 
150 
400 
3 
66 
  
  
  
  
Total 977 
 
Handsearch 
 
Addiction 
Journal of Substance 
Abuse Treatment 
Journal of Clinical 
Child and Adolescent 
Psychology 
Journal of Consulting & 
Clinical Psychology 
Research on Social 
Work Practice 
2,037 
776 
 
391 
 
 
527 
 
458 
  
  
Snowball 1 
Expert list 0 
  
Total 4,190 
 
1,808 excluded for being 
duplicates. 
10,779  potential relevant studies (database: 
5,612, grey: 977, hand search etc.: 4,190) to be 
screened for retrieval. 
99 retrieved for full text screening. 
10,680 full texts 
excluded for not 
fulfilling the 1. level 
screening 
questions. 
2 full texts met inclusion criteria and were 
assessed for data extraction. 
94 papers were 
excluded for not 
fulfilling the second 
level screening 
questions.  
3 papers were 
excluded for being 
duplicates  
 
. 
. 
2 studies met the eligibility criteria and where 
included in the review. 
 77      The Campbell Collaboration | www.campbellcollaboration.org 
12 Differences between review 
and protocol 
In the protocol it was stated in section 3.4.7 that statistically significant 
heterogeneity among primary outcome studies will be been assessed with Chi-
squared (Q) test and I-squared (Higgins, Thompson, Deeks, & Altman, 2003). A 
significant Q (P<.05) and I-squared of at least 50 per cent will be considered as 
statistical heterogeneity. The assessment of heterogeneity has been changed to: 
Heterogeneity among primary outcome studies was assessed with Chi-squared (Q) 
test, and the I-squared, and τ-squared statistics (Higgins, Thompson, Deeks, & 
Altman, 2003). Any interpretation of the Chi-squared test was made cautiously on 
account of its low statistical power. 
 
